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Abstract 
The main objective of this thesis was to investigate the different factors affecting the embryo 
recovery in superovulated buffaloes. Several hypotheses have been formulated over the years to 
explain the low embryo recovery recorded in this species after superovulatory treatment, among 
which the most likely is a failure of ovum capture. Before addressing the major issue, other 
experiments were carried out in order to select both the donors and the most suitable superstimulation 
treatment. Indeed, another critical factor limiting the application of this technology in buffalo is the 
high between-animal variability in the number of embryos produced. Therefore, the aim of 
Experiment 1 was to evaluate whether the Anti-Mullerian hormone (AMH) can be used as a reliable 
marker to select good donors in addition to the screening of the antral follicular count (AFC), before 
enrolling buffaloes in embryo production programs. In order to do so, 54 multiparous Italian 
Mediterranean Buffalo cows were synchronized by double prostaglandin administration spaced 11 
days apart and were slaughtered at a local authorized abattoir 6 days after the second administration. 
On all animals AFC, recovery rate and oocyte quality were recorded, and both plasma and follicular 
fluid (FF) were collected for AMH determination. In a representative number (n=22) the mRNA 
expression of six genes (AMHR2, CYP19A1, FSHR, LHR, TP53INP1, and CASP3) was analysed in 
granulosa cells (GCs). Finally, buffaloes were classified according to the AFC as good (≥ 12 
follicles) and bad (< 12 follicles) donors, in order to evaluate the differences in reproductive 
parameters. Differences in AMH concentration in FF and gene expression in GCs among classes of 
follicles were analysed by ANOVA. Pearson correlation analysis was carried out to evaluate the 
relationship between AMH and the AFC, as well as among other reproductive parameters. The 
differences in AMH plasma levels and reproductive parameters between good and bad donors were 
analysed by Student’s t test. The results of Experiment 1 showed a positive correlation (r = 0.31; 
P<0.05) between intrafollicular AMH concentration and the AFC in buffalo. Interestingly, good 
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donors had a higher (P < 0.05) concentration of AMH in FF and AMHR2 levels in small follicles and 
higher (P < 0.05) LHR levels in large follicles than bad donors. However, no correlation was found 
with the plasmatic AMH levels, likely due to the poor sensitivity of the available kits. Thus, one of 
the future objectives could be to assess a more reliable specific assay in order to use this as a marker 
to screen donors. The aim of Experiment 2 was to evaluate the efficacy of replacing the last four FSH 
injections with a single administration of 1000 IU of eCG compared to the conventional FSH 
decreasing doses superovulation protocol. The study was carried out on 20 multiparous Italian 
Mediterranean buffaloes synchronized with a common double prostaglandin protocol. Then, animals 
were divided in two groups: one treated with a superovulatory protocol with FSH decreasing doses 
and one with the eCG replacing the last four FSH administrations. All cows were artificially 
inseminated at oestrus and ultrasonographic investigations in the two groups were carried out to 
assess follicular dynamics and to establish the number and size of corpora lutea on the ovaries. 
Differences between treatments were analysed by Student’s t test. It was demonstrated that the 
replacement of the last four injections of FSH with a single administration of eCG within a 
superovulation protocol in buffalo is not recommended, due to the presence of a high number of 
anovulatory follicles at the moment of flushing, and a reduced number of ova compared to the 
conventional FSH treatment (3.0 ± 0.6 vs 6.6 ± 0.9 and 2.0 ± 1.2 vs 0.8 ± 0.6 respectively). However, 
a poor recovery rate in relation to the number of corpus luteum (CL) recorded in both protocols 
remains. In order to select the most reliable control group for the superovulation study, the aim of 
Experiment 3 was to evaluate the relationship between the ovarian follicular response at the start of 
an Ovsynch program and the pregnancy outcome. The study involved 116 pluriparous buffaloes that 
were synchronized by Ovsynch–TAI program, involving the administration of GnRH on Day 0 
(GnRH1), PGF2a on Day 7, and GnRH on Day 9 (GnRH2), with timed artificial insemination (TAI) 
carried out on Day 10. Ovarian ultrasound examinations were undertaken on days 0, 2, 7, 9, 10, and 
11 to record total follicles, the dimensions of follicles greater than 0.75 cm, dimensions of the CL, 
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and the occurrence of ovulation. Blood concentrations of progesterone (P4) were measured on days 0 
and 10 and 10 days after TAI. Pregnancy status was determined on days 27 and 45 after TAI to 
calculate late embryonic mortality. The data were analysed by ANOVA and multiple logistic 
regression. The results of Experiment 3 showed that only 60% of the buffaloes ovulated after the first 
GnRH on day 0 of the Ovsynch-TAI program. A higher proportion (P <0.01) of buffaloes that 
ovulated after GnRH1 had a vascularized corpus luteum (CL) on day 7. Furthermore, a greater 
proportion (P<0.05) of buffaloes that ovulated after GnRH1 was in oestrus and both a higher 
ovulation rate and pregnancy to AI were observed compared to buffaloes that did not ovulate. The 
results of the experiment 3 showed how important is the ovulation after the 1
st
 GnRH to the 
pregnancy outcome, during Ovsynch-TAI program. This is due to both an optimized response of the 
CL to PGF2α on day 7 and a better response of the preovulatory follicle to second GnRH on day 9, 
increasing the likelihood of pregnancy to TAI. The results of this experiment allowed us to better 
plan the experiment 4, by selecting the animals that ovulated after the 1
st
 GnRH as a control group to 
compare with superovulated animals. Therefore, the aim of Experiment 4 was to compare the 
morphological parameters of the follicles and the steroid profile (progesterone and oestradiol) both in 
plasma and follicular fluid in the peri-ovulatory period in superovulated vs synchronized buffaloes. 
Thirty-five multiparous Italian Mediterranean Buffalo cows were randomLy divided into two groups: 
a group (n = 25) was synchronized by Ovsynch and another group (n=10) was superovulated with 
conventional FSH protocol and all of them were sacrificed 18 h after GnRH. On all animals AFC, 
recovery rate and oocyte quality were recorded, and both plasma and FF were collected for steroid 
profile determination. In addition, out of 10 animals (5/group), GCs were collected to analyse the 
mRNA expression of gonadotropin receptors LHR and FSHR while oviducts were collected to 
evaluate the mRNA expression of steroid receptors ER1 and PGR, VEGF and the VEGF receptor 
FLK1. Differences in morphological follicular parameters, as well as in the concentration of 
progesterone and oestradiol both in plasma and in follicular fluid were analysed by ANOVA, while 
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differences in the recovery rate and in the percentage of oocytes showing cumulus expansion were 
analysed by Chi Square Test. Experiment 4 demonstrated that in superovulated animals the E2 and 
P4 concentrations in FF were lower (P<0.05) than in synchronized animals. Interestingly, both the 
recovery rate and the percentage of oocytes exhibiting proper cumulus expansion decreased (P<0.05) 
in the superovulated animals. Finally, in superovulated buffaloes a decreased expression of both ER1 
and the VEGF receptor FLK1 in the infundibulum and an increased expression of FSHR in granulosa 
cells were observed (P<0.05). The results of the latter experiment suggest that the exogenous FSH 
treatment has probably increased the expression of FSHR in granulosa cells that was not followed by 
a parallel increase of oestradiol synthesis, eliciting an alteration of the granulosa cell function. The 
consequent altered steroid profile could affect in turn both the cumulus cells expansion during 
maturation, and the contraction-relaxation of the infundibulum, confirming the hypothesis of a failure 
in ovum capture in superovulated buffaloes. In conclusion, the results of this thesis taken together 
highlight the limitations of MOET in buffalo, suggesting that at present the only way to improve the 
intensity of genetic selection, through the maternal lineage, in this species is the OPU-IVEP 
technology. Indeed, buffaloes do respond to the gonadotropin treatment with multiple ovulations but 
the ova capture is severely impaired, resulting in poor embryo recovery. Nevertheless, the outputs of 
this thesis led to an improved knowledge and understanding of the limiting factors of the 
superovulation technique in this species. 
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Buffalo (Bubalus bubalis) breeding in the world  
 
The world buffalo population amounts to about 190 million of heads (FAO, 2010) distributed as 
follows: 96.4% in Asia (mainly concentrated in India, China and Pakistan), 2.9% in Africa 
(especially in Egypt) and the rest in Europe (particularly in Italy, but also in Romania, Georgia, and 
Bulgaria) and Latin America. In the zoological scale, the buffalo is in the class Mammalia, order 
Artiodactyla, Ruminantia subordinate, family Bovidae, sub-family Bovinae, gender Bubalus, species 
Bubalus bubalis. This species is divided into two groups (Macgregor, 1939): Bubalus bubalis sp. 
known as “Water or River buffalo” with 50 pairs of chromosomes bred in India and in western 
countries and Bubalus bubalis var. kerebau called “Carabao or Swamp buffalo” with 48 pairs of 
chromosomes, present in the countries of Southeast Asia.  
In the last years, interest in the world regarding buffalo breeding has increased. This is because in 
tropical countries environmental and climatic conditions make buffalo an irreplaceable milk 
producer; indeed, this specie best suit to satisfy animal protein demand, as it is easy fitting, rustic, 
long-lived and parasite resistant. Moreover, buffaloes have a high capacity for adaptation across 
broad climatic zones. The perfect interaction among reproductive seasonality, environmental 
conditions and forage availability throughout the year allows the buffalo to be able to compensate the 
loss of bovine milk recorded during the unfavourable season and to produce animal proteins at 
competitive costs, exploiting pastures that are typically limiting cattle production (Zicarelli, 1994a, 
Campanile et al., 2010). The good feed conversion efficiency of buffaloes and relatively low 
maintenance requirements are attributes, which make them ideal in low-input, low-cost production 
systems (Zicarelli, 1994a). The buffalo bred in Italy is part of a large family of River type. Until few 
years ago it was called Mediterranean type buffalo, while in 2001 the Ministry of Agriculture and 
Forestry, thanks to long isolation and lack of crossbreeding with other strains, recognized the 
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"Mediterranean Italian buffalo" breed (Ministerial Decree 201992 of 05/07/2001). Therefore, the 
buffalo bred in Italy shows a degree of "purity", result of obvious morphological and functional 
differentiation. In Italy, buffalo is an important economic resource, especially for the regions 
traditionally involved in the rearing of this species. The largest concentration of heads can be found 
in Campania, in Caserta and Salerno provinces, where 66% of the Italian total population is bred 
(Istituto Nazionale di Statistica, 2013). In these areas, buffalo breeders have constantly grown both in 
professional and managerial terms, fine-tuning and perfecting breeding techniques and coming to an 
efficient intensive or semi-intensive approach. This advance has been made possible selecting only 
the most productive buffaloes, improving the quantity and the quality of milk, with the aim to 
increase productive and genetic value and transform a marginal sector into an area with great 
economic potential. In our country, the profitability of this species is particularly linked to its well-
known product: the “Mozzarella di Bufala Campana” cheese, enhanced and protected by a 
Denomination of Protected Origin (DPO) trademark and, above all, recognized in most of the 
countries. Therefore, in Italy, the commercialization of milk for mozzarella cheese production 
represents the main income of buffalo breeding.  
It is worth to point out that about 98% of the buffaloes in the world is bred in developing countries 
that are interested in Italian dairy genetic "material" to crossbreed the local buffaloes with the highly 
productive Mediterranean buffalo, in order to increase animal proteins and, most of all, meet human 
needs. However, the ever-growing trend of milk request and the necessity to cut down fixed 
production costs make the adoption of an improving production plan essential to farming. In this 
scenario, the competitiveness of buffalo breeding in Italy is necessarily linked to the use of 
biotechnologies of reproduction that consent to plan selective targets in a shorter time. In addition, 
reproductive technologies are fundamental also to meet the constantly increasing requests of the 
Mediterranean buffalo semen and embryos from many countries. 
  
9 
 
Reproductive biotechnologies  
 
Reproductive biotechnologies are undoubtedly the most emblematic strategies of applied research in 
the field of life sciences and animal husbandry. These new technologies have significantly 
contributed to the evolution of breeding in the last 60 years (Thibier, 2005), laying the basis for a 
radical transformation of animal husbandry processing and production systems. One of the key 
features of a modern farm in order to be competitive in the market is certainly to achieve 
considerable genetic improvement in short time, without neglecting the needs of consumers who are 
increasingly sensitive to both the quality of product and animal welfare. Reproductive 
biotechnologies allow planning selective directions in a shorter time, allowing the distribution of elite 
buffalo genes, the reduction in generation interval and providing continued genetic gain, resulting in 
an increasing production of buffalo meat and milk. In this species the reproductive technologies that 
offer most of the benefits are: Artificial Insemination (AI), which is a critical tool to enhance the 
paternal contribution to the genetic improvement, Multiple Ovulation (MO) and Embryo Transfer 
(ET) programs which increase the intensity of genetic selection, through the maternal lineage, 
reducing generation intervals and the Ovum Pick-up (OPU) linked to the in vitro embryo production 
(IVEP), the technology that currently allows to obtain the greatest number of transferable embryos 
from each donor over a long term (Gasparrini, 2002). 
 
Artificial Insemination (AI) 
This technique consists in the collection of semen from animals of high genetic merit and its dilution 
and utilization in recipient females. Artificial insemination (AI) offers many advantages over natural 
breeding: it allows the choice of the best bulls to improve the genetic make-up of a buffalo herd and 
gives the opportunity to quickly obtain multiple generations of the same bull. The application of this 
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technique is worldwide carried out in several animal species, as well as in humans. In particular, in 
the field of animal science, AI provides sanitary, genetic and economic advantages. From a sanitary 
point of view, it avoids the transmission of venereal diseases, as well as other infectious diseases, 
since the males that are selected for AI undergo severe sanitary controls to verify that they have not 
been in contact with pathogens, such as vibrio or trichomonas, and that there is no brucellosis, 
leucosis, tuberculosis or IBR infection going on. These risks are vastly reduced with the use of AI. 
From a genetic point of view, AI allows a quicker evaluation of sires through progeny testing of 
daughters, whose productive, morphological and reproductive characteristics can be tested. It has 
been estimated that one bull can mate 20 females in one month by natural insemination and its 
reproductive activity lasts approximately 12 years. By using AI, taking into consideration the number 
of straws that can be obtained from a single ejaculate following dilution and freezing, one bull can 
produce up to 200.000 calves, respect to the 3000 obtained by natural insemination. Another benefit 
of this reproductive technique is the availability of semen even after death of proven sires and the 
possibility to transport worldwide frozen semen promoting a genetic improvement worldwide. 
Another important aspect related to AI is the customization of the best sire to the recipient 
characteristics. This allows corrections of some morphological and productive defective traits of 
recipients that will not be carried over to their progeny resulting in calves with different 
characteristics. The economic advantages linked to the utilization of AI are mainly due to a better 
management of the farm. Bulls are expensive to rear, relatively unproductive, vulnerable to disease or 
accident and often infertile. In addition, they need higher feed requirement, special housing and 
handling equipment. This was a major stimulus to the initial setting up of AI services. By using AI, 
farmers can save on space otherwise used by bulls, for a better farm management, and erase the 
possibility of any dangerous situation linked to their aggressiveness.  
Despite this, the application of AI has some possible disadvantages. The major limitation is the long 
time needed in order to prove sires through progeny testing, i.e. testing of their daughters for milk 
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production. In buffaloes, this process requires at least four to five years, since: over 10 months are 
required for pregnancy, at least other 20 months are needed to reach puberty and an additional 10 
months are required for the subsequent pregnancy of the progeny. Data will be analysed only at the 
end of the first lactation, and after all this time it could be possible that bull shows negative effects on 
milk production and hence must be excluded from reproduction. Moreover, currently there are still 
few proven sires across many farms and this may cause, in the long run, a considerable increase of 
consanguinity and inbreeding. In order to avoid this problem, a better specific breeding program is 
needed.  
Although buffaloes are probably among the easiest mammals to be trained to serve an artificial 
vagina (Sansone et al., 2000), natural mating is still widely used in buffalo herds. Indeed, the use of 
AI in both Swamp and River buffaloes is still marginal for different reasons. The implementation of 
AI in Swamp buffaloes has its drawbacks in the low number of heads per owner, lack of proper heat 
detection and the overall poor management. On the contrary, in intensive River buffalo breeding, the 
use of AI has been kept marginal until two decades ago, mainly due to lack of truly superior progeny 
tested bulls and, most of all, to unacceptable low pregnancy rates, significantly affected by the 
seasonality of the species (Campanile et al., 2005, 2007a, 2008), when using both natural or 
synchronized oestrus (Zicarelli et al., 1997a). At our latitude, AI is strongly influenced by 
seasonality, as shown by the high incidence of embryonic loss (20-40%) during seasons with a higher 
number of light hours (Campanile et al., 2005, 2007a, 2007b). Furthermore, Rossi et al., (2014) 
reported a marked seasonal variation in the response of Italian buffaloes to synchronization protocols. 
Buffalo is a short-day breeder, showing an increase of reproductive activity when daylight length 
decreases (Zicarelli, 1997; Campanile et al., 2010). The influence of photoperiod results in seasonal 
cycles in conception, calving and milk production (Campanile et al., 2010). This reproductive pattern 
depends on the duration and the intensity of the light source. Only around the equatorial belt, where 
the light/dark ratio is similar throughout the year, the reproductive season is more influenced by 
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forage availability (Vale et al., 1990). In Italy, in order to meet the market demand, the out-of-
breeding season mating strategy is applied, that entails the interruption of natural mating or the use of 
AI between October and February in adult females and between September and March in heifers. It 
follows that animals are mainly mated out of the natural breeding season, when reproductive 
efficiency is low and seasonal anoestrus may occur. This results in high incidence of embryonic 
mortality (Campanile et al 2005, 2007). Embryonic loss during the unfavourable season is in part due 
to compromised luteal function, leading to reduced progesterone level (Campanile et al., 2005, 2007), 
and in part to impaired oocyte competence (Di Francesco et al., 2012). Indeed, an appropriate CL 
development, vascularization and function during the first weeks after AI affects pregnancy outcome 
(Russo et al., 2010, Vecchio et al., 2012). In addition, the size that the embryo reaches on day 25 
after AI is important for subsequent pregnancy maintenance (Neglia et al 2012). Indeed, a delayed 
embryonic development, associated to low P4 levels, is reflected in altered proteomic profile of the 
embryonic chorioamnion and uterine caruncles (Balestreri et al., 2013) and abnormal embryo 
transcriptome (Strazzullo et al., 2014). In order to counteract early embryonic mortality, hormonal 
treatments to suppress luteolytic mechanisms have been given either on the day of AI or on day 5 
after AI (Neglia et al.,2008; Campanile et al., 2007; Pandey et al., 2015, 2016). However, the major 
cause of embryonic loss in buffalo is late embryonic mortality (LEM), occurring between 25 and 45 
days, where P4 decline occurs later, after day 10 (Russo et al., 2010) affecting embryo attachment, by 
altering MUC-1 expression in the uterine epithelium. In fact, it was demonstrated that treatment with 
progesterone, GnRH agonist and hCG on day 25 post-AI was effective to decrease the incidence of 
LEM (Campanile et al., 2008).  
Peculiarities of the oestrous cycle, such as the high variability in the duration of the oestrous cycle 
and oestrus, the high incidence of double ovulations and the lower expression of oestrous behaviour, 
also delayed the application of AI in this species. The oestrous cycle in fact varies from 16 to 28 days 
(Neglia et al., 2007; Baruselli et al., 1997); in buffaloes showing regular oestrous cycles the length of 
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oestrus is around 10-20 h during the breeding season (Vale et al., 1984), although a large variability 
(from 2 to 72 h) is observed, particularly out of the breeding season (Baruselli, 2001). Furthermore, 
the expression of oestrus, as well as the oestrus-associated mounting behaviour are less intense 
compared with cattle (Ohashi, 1994). It has been reported that only 3.44% of the females present 
homosexual behaviour (Baruselli, 2001).  
Recently though, an improvement of the efficiency in protocols for synchronization of oestrus and 
ovulation has been reported in buffaloes (Neglia et al., 2008, 2016), paving the road for a wider 
implementation of assisted reproduction in this species. The efficiency of AI has doubled (25–50% 
pregnancy rate) over a period of approximately 20 years (Zicarelli et al., 1997; Baruselli et al., 2001a; 
Campanile et al., 2011; Neglia et al., 2015). Currently, AI is routinely applied in intensive river 
buffalo systems and the good results obtained with sexed semen (Campanile et al., 2011; 2013) make 
us foresee an even wider diffusion in the field.  
Further aspects still need to be considered and investigated in order to spread diffusion of AI in 
buffalo management worldwide. Among these, one of the most important is the semen 
cryopreservation procedures and hence, the quality of frozen-thawed semen that is known to be 
related to low fertility rates in buffalo (Kumaresan et al. 2005, 2006; Shukla and Misra 2007).  
 
Multiple Ovulation (MO) and Embryo Transfer (ET) 
The MOET is the technology currently used to get half of the embryos produced for commercial 
purposes in the world (IETS, 2015). This technique consists of the administration of exogenous 
hormones in order to obtain multiple ovulations in animals that normally ovulate a single follicle. 
MOET schemes are used to increase the intensity of genetic selection, reducing generation intervals, 
and to select bulls to be used for AI (Gearheart et al., 1989). In this case, previously selected donor 
dams are inseminated with the semen of bulls showing superior traits. As regarding the offspring, 
females are used only for production, while males will wait the production results of their sisters 
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(Smith and Ruane, 1987). The difference with AI is that males are tested and chosen according to the 
productive performances of their sisters, instead of their offspring and this makes possible to 
genetically test a bull in 3.5 years instead of 5.5 years. (Smith and Ruane, 1987).   
In cattle MOET programs have improved over the years; however, wide ranges in superovulatory 
response and embryo yield in several different species have been reported (Armstrong, 1993). In fact, 
Gordon (1975) stated in 1975 “although superovulation as a method of obtaining a supply of eggs has 
taken many forms over the years; it still leaves much to be desired. In fact, it must still be regarded as 
a major problem blocking progress in exploiting egg transfer in increasing numbers of progeny from 
genetically superior cattle”. Although considerable recent progress has been made in the study of 
ovarian physiology, manipulation of ovarian function and gonadotropin biochemistry, factors 
inherent to the donor animal which affect superovulatory response are only partially understood. 
Thus, a high degree of unpredictability in superovulatory response still exists more than 35 years 
later, creating problems, which affect the efficiency and profitability of commercial embryo transfer. 
However, currently, MOET is still the technique that produces more embryos in the world, for a total 
of 600,000 embryos per year, of which about 460,000 are transferred (IETS, 2015). Traditionally, 
superovulation was performed between the 9
th
 and the 11
th
 day of the bovine oestrous cycle, in 
coincidence with the emergence of the second follicular wave. Subsequently, on day 6-7 after AI 
embryos are recovered by flushing the uterine horns of the donors with isotonic buffered solutions. 
The recovery of embryos is performed in different ways: in the early development stages of the 
technique, embryos were recovered either surgically, or by laparoscopy, or by transvaginal insertion 
of a catheter into the uterus. Further development resulted in a technique involving trans-cervical 
insertion of a three-way catheter to flush the uterine horns. Embryos are evaluated under a 
microscope to assess suitability for direct transfer or for cryopreservation. After oestrus 
synchronization of the recipients, the embryos are transferred in surrogate females for the gestation.  
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Several extrinsic and intrinsic limiting factors influence the response to MO in buffalo that will be 
discussed deeply in the next chapter. Indeed, although the birth of the first embryo transfer buffalo 
calf occurred more than three decades ago (Drost et al. 1983), the application of MOET in this 
species is still limited, due to poor efficiency compared to cattle (Drost 2007; Madan et al 1996; 
Carvalho et al. 2002). In fact, using this technique in bovine, the mean embryo recovery per animal is 
5, whereas in buffalo there is an average recovery of 1-2.5/donor, (Zicarelli 1997; Baruselli et al., 
1999; Carvalho et al., 2002; Misra and Pant, 2003; Misra and Tyagi, 2007; Neglia et al., 2010; Qin et 
al., 2012). Due to the low and inconsistent efficiency of MOET treatments in this species (Misra et al, 
1997; Zicarelli et al, 1997), there is a worldwide increasing interest in large-scale in vitro production 
of buffalo embryos for faster propagation of superior germplasm and to enhance genetic progress 
through the maternal contribution. 
 
Ovum-pick up and in vitro embryo production 
The advent of Ovum Pick-Up (OPU), i.e. the in vivo oocyte collection from live donors, has 
effectively increased the worldwide interest in the in vitro embryo production (IVEP) procedure, as a 
valid alternative to the in vivo embryo production. It consists in an ultrasound guided transvaginal 
procedure to recover oocytes from a live donor. It is an alternative technique to MOET because it can 
be performed on a wider typology of donors, such as acyclic, prepubertal animals (Armstrong et al., 
1992), pregnant cows up to the 3
rd
-4
th
 month of gestation, animals with non-perfect conditions of the 
reproductive tract (Galli et al., 2001) or at the end of their productive career and animals that are not 
sensitive to the hormonal stimulation treatments. Moreover, since it does not interfere with animal 
reproductive and productive cycles and does not require any hormonal pre-treatment, unlike MOET 
method, it has no negative impact on the treated animal and may have a therapeutic effect in animals 
with ovarian cysts or similar diseases. The optimal interval between aspiration sessions is 3-4 days 
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(Boni, 1997; Galli et al., 2001). In fact, the aspiration of all follicles with diameter >2 mm, resets the 
oestrous cycle and avoids the dominance of one follicle over the subordinates. 
The combined OPU and IVEP technology is currently the most efficient tool for increasing the 
number of transferable embryos obtainable per donor. According to the International Embryo 
Transfer Society statistics, the number of embryos produced in vitro and transferred into recipients 
has increased more than 10 times (Stroud, 2011) in the last dozen years, approaching the number of 
embryos produced in vivo by superovulation (Fig. 1). 
 
Figure 1. Comparison of the number of in vivo and in vitro embryos transferred annually for the last 
decade. 
 
 
 
This indicates that OPU and IVP is considered a reliable and cost-effective technique and has 
acquired a role in cattle breeding.  
In buffalo, this technology has even greater potentials because, as mentioned before, superovulation 
gives poor results compared with cattle (Gasparrini 2002) and it has never had a real impact on 
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buffalo breeding programs. This is both because of the limited number of embryos that can be 
recovered and low proportion of animals responding to the hormonal stimulation (Zicarelli, 1997b; 
Techakumph et al., 2001), as well as because of the impossibility to repeat continuously the MOET 
treatments over a long-term since multiple ovulations can be induced only in cyclic animals, and it is 
likely that buffalo cows enter seasonal anoestrus. Because of these limits, the OPU technology has 
always been of great interest also in buffalo breeding. Boni et al. (1994) reported the first OPUs in 
buffalo and the procedure is performed exactly in the same way as in cattle. Because of the great 
value of the female offspring in buffalo herds, the combination of OPU with cryopreservation (Galli 
et al., 2012) and use of sexed semen for IVF (Liang et al., 2008) offer the opportunity to accelerate 
the genetic gain in the buffalo industry. The competitiveness of OPU-IVEP becomes overwhelming 
when donors are selected based on their folliculogenetic potentials. Earlier OPU trials performed in 
the Mediterranean Italian Buffalo reported an extreme individual variability in the number of follicles 
(Gasparrini, 2002; Neglia et al., 2003; 2011a). Gasparrini et al., (2014) reported that in buffalo the 
donor influences not only the number of recoverable oocytes but also the developmental competence, 
i.e. the capacity to develop in vitro up to the blastocyst stage, as shown by great individual variability 
in the blastocyst rates (4.3–22.8%). Moreover, the number of small follicles registered at the start of 
OPU may predict the number of superior quality oocytes that can be obtained from an animal during 
the subsequent two months. This is particularly important in buffalo, in which the major limitation is 
the low number of recoverable oocytes (Gasparrini, 2011). Therefore, for the application of OPU-
IVEP technology in the field, it is fundamental to select the best donors on the basis of the follicular 
population before enrolling them in programs to obtain a number of embryos sufficient to offset the 
laboratory costs. Moreover, it has been demonstrated over the years that improvements in IVEP are 
possible through the optimization of each procedural step, especially when taking into account 
species-specific differences, as shown by the higher blastocyst rates reported over recent years 
(Gasparrini et al., 2006a, 2008). 
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However, although the buffalo IVEP system has greatly improved through the years, leading to high 
blastocyst yields (Gasparrini et al., 2006a; Neglia et al., 2003) and to the production of offspring 
(Huang et al., 2005; Hufana-Duran et al., 2004; Neglia et al., 2004; Sà Filho et al., 2005), this 
technology is still far from being commercially viable. As mentioned before the low IVEP efficiency 
recorded in buffalo compared to cattle is in part due to peculiarities of the reproductive physiology of 
buffalo that are not easily modifiable, such as the low number of oocytes recovered and their poor 
quality. Is it known that in vitro produced embryos are still less viable and cryotolerant than their in 
vivo counterparts (Leibo and Loskutoff, 1993; Hasler, 2000). In addition, in vitro produced embryos 
display several alterations in morphology, metabolism and gene expression that may result in poorer 
cryotolerance, higher incidence of embryonic loss and hence lower pregnancy to term after ET, as 
well as foetal abnormalities, post-implantation defects and long term effects, all symptoms of the 
well described large offspring syndrome (Bertolini et al. 2002; Crosier et al. 2002; Rizos et al., 2008). 
It is also worth pointing out that, although IVEP allows a greater embryo yield over a medium-long 
term, resulting in a higher number of offspring, the relative efficiency is lower and costs of 
production much higher than MOET. 
In addition, unlike cattle, for economic reasons, buffalo cows are usually slaughtered when they are 
old or when their fertility and productivity are compromised (12 years in Italy and even longer in 
China and South East Asia). This results in a further decrease of the number of competent oocytes 
recoverable in the case of abattoir-derived ovaries as a source of gametes.  
Indeed, MOET could be a cheaper alternative or a complementary approach for embryo production, 
suitable for practitioners, as it does not require expensive laboratory facilities. It follows that an 
improvement of MOET efficiency in buffalo, through a better comprehension of the factors involved 
in the failure of embryo recovery may provide a valid parallel tool to satisfy the increasing embryo 
demand from many countries of the world. As this is the major topic of this thesis, a more detailed 
update of MOET technology in cattle and buffalo is provided below.  
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Basic concepts on superovulation 
 
In order to achieve a better comprehension of the superovulation schedules some information on 
follicular dynamics should be provided. In most domesticated animal species (e.g. cow, sheep, goat, 
horse) follicular development during the oestrous cycle takes place in a wave-like pattern (Evans et 
al., 1994). Normally, bovine cycles present two or three growth waves but cycles with one or four 
waves have also been observed (De Rensis and Peters, 1999). As well as the other species, buffalo 
follicular cycles are organized in a wave-like pattern, in both natural and synchronized oestrus 
(Baruselli et al., 1997; Neglia et al., 2007, Campanile et al., 2010). More than 60% of buffaloes show 
two waves for cycle and the remaining shows three waves for cycle. The length of the cycle is 
normally 23-24 days, although shorter (16 days) and longer (26-30 days) cycles have been observed 
(Neglia et al., 2007). In buffaloes having a two-wave growth pattern, the emergency of the first 
growth wave occurs on day 1 and the second on days 12-14. In those with a three-wave growth 
pattern the second and the third wave come out on days 11 and 20, respectively (Neglia et al., 2007). 
During each wave, the phenomena of recruitment, selection and dominance occur (Ginther et a., 
2001). At the moment of the recruitment, the increasing circulating levels of FSH allow the growth of 
a cohort of 6-8 follicles (Baruselli et al., 1997). Later, the phenomenon of selection and dominance 
takes place: in buffalo, a monovular species, normally only a single follicle will develop into a 
dominant follicle, causing the regression of the other. The dominance occurs when the dominant 
follicle, after 3 days of growth, reaches the diameter of approximately 7.4 mm (Gimenes et al., 2011). 
During the deviation phase, the follicle acquires the LH receptors. LH plays a key role since, before 
this time, all growing follicles could become dominant, whereas after deviation only the largest 
follicle reaches the dominance phase, letting the others regress. Moreover, some studies carried out in 
bovine heifers demonstrated that LH receptors emerge in granulosa cells of the future dominant 
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follicle about 8 hours before the beginning of deviation (Ginther et al., 2001). Moreover, the 
intrafollicular oestradiol: progesterone ratio declines, laying the basis for the ovulation (Mihm et al., 
2006). 
 
Hormonal control for optimizing superovulation 
As introduced above, the aim of this technique is to overcome the physiological limitations of one 
ovulation per buffalo oestrous cycle. For this reason, the follicular dynamics is altered and modulated 
by the exogenous administration of hormones some days in advance of the anticipated normal oestrus 
in order to obtain multiple ovulations in the donor. This is inevitably achieved by avoiding the 
dominance phase, thus allowing the growth of a large number of dominant follicles to acquire 
ovulatory capability. In the first trials carried out on superovulation in both cattle and buffalo the 
treatment conventionally started during mid-cycle. Bó et al. (1995) reported that a greater 
superovulatory response is obtained when the superstimulatory treatments begun 8 to 12 days after 
oestrus. Using ultrasonography, it was demonstrated that these days would correspond approximately 
to the emergence of the second follicular wave, when on the ovary there is a cohort of growing 
follicles. Due to this reason, the protocols used nowadays involve the initiation of superstimulatory 
treatments after the exogenous control of follicular wave emergence. Different methods have been 
used to elude the effect of the dominant follicle and reduce the atresia (see below), such as hormones 
administration (oestradiol, progesterone, GnRH, eCG, etc.), or mechanical techniques, as the ablation 
of the dominant follicle by ovum pick-up (Zicarelli et al., 1995). 
Only with a synchronized cycle, the superovulatory treatment could be initiated. Normally, MOET is 
carried out with an intravaginal device releasing progesterone, on one hand to avoid an endogenous 
LH peak and ensure synchronous growth of all follicles and, on the other hand, to ensure high 
progesterone levels that are beneficial for subsequent embryo development (Bó and Mapletoft, 2014). 
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Several hormones have been utilised to manipulate the follicular development in both bovine 
(Mapletoft and Bó, 2012; Bó and Mapletoft, 2014) and buffalo (Zicarelli, 1997; Misra and Tyagi 
2007). In particular, three different types of gonadotropins are used: 
1) Pituitary extracts of porcine or other domestic animal origin; 
2) equine chorionic gonadotropin (eCG); 
3) human menopausal gonadotropin (hMG). 
These hormones show different characteristics that will be analysed more in details below. 
Conventionally an administration of prostaglandin F2α (PGF2α) is made one day before the end of the 
superovulatory treatment, to ensure corpus luteum (CL) regression and the donors are naturally or 
artificially inseminated about 60 and 74 hours after this administration. In order to apply fixed-time 
AI a GnRH injection can be given to synchronize the ovulation, on the day before AI. 
 
Uterine flushing 
Six days after insemination, the non-surgical embryo collection is carried out by performing a uterine 
flushing with the aid of a Fooley catheter. This is a flexible tube that is inserted in the uterus by using 
a mandrel until about 2/3 of each uterine horn. The Fooley catheter is characterized by two separated 
channels (2-way catheter), running down its length. One channel is open at both ends and allows the 
inflow and outflow of flushing medium. The other lumen has a valve on the outside end and connects 
to a balloon at the tip; the balloon is inflated with air when it lies inside the uterine horn in order to 
stop it from slipping out. The Fooley catheter (Fig. 2) is inserted through the vagina, cervix and into 
one of the uterine horns where the balloon is inflated. Due to the presence of an intercornual ligament 
buffaloes have the uterine horns less extensible and elastic than those of cattle (Vittoria, 1997). This 
anatomic feature makes the insertion of the catheter not as easy as in cattle and expose the basis of 
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the horn to the risk of laceration if the balloon pressure is not suitably regulated (Zicarelli, 1994). 
Usually 8 to 22 cc of air are used in buffalo species (Zicarelli, 1997). 
 
Figure 2. Fooley catheter  
 
 
The inflated balloon will seal off the anterior portion of the uterine horn, avoiding fluid from getting 
out of the uterus when the flushing medium is inserted into the uterine horn to recover the embryos. 
After a certain amount (around 500-750 mL) of medium is “flushed” into the uterus, the fluid is then 
recovered from the uterus and this process is repeated on the other horn. Each uterine horn is flushed 
with commercially available, complete, and ready-to-use flushing media containing antibiotics and 
bovine serum albumin as a source of protein. Some of them also contain surfactants to minimize the 
formation of foam and bubbles when the embryo is searched in the Petri dish. In the past, the flushing 
medium consisted primarily of Dulbecco's phosphate buffered saline (PBS) with antibiotics and 1% 
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foetal/calf bovine serum (FBS/FCS) or alternatively 0.1% bovine serum albumin (BSA). This 
solution is actually largely utilized in the world for its low costs. It is worth to point out that the 
flushing solutions should be maintained at temperature of 30-35°C, to avoid thermal shock to the 
embryos at the recovery. 
Buffalo embryos have a faster rate of development compared to bovine (Chantaraprateep et al., 1989; 
Drost and Elsden, 1985; Anwar and Ullah, 1998; Misra et al., 1998) and these results have been 
confirmed from further researches performed in vitro, demonstrating that buffalo embryos are 12 to 
24 hours more advanced than the bovine counterparts (Galli et al., 2001). Moreover, oocytes and 
embryos in buffaloes reside in the oviduct for 74-100 hours post-fertilization (Karaivanov et al., 
1987) and thus reach the uterus 4.5-5 days after fertilization. Likewise, in Nili-Ravi buffaloes (Anwar 
and Ullah, 1998), the embryos are in the oviduct after 85 hours post insemination and at 108 hours 
most of them (78%) descend into the uterus. It seems that buffalo embryos are at morula stage when 
they reach the uterus (Anwar and Ullah, 1998), similarly to that described in bovine at 120 hours 
(Betteridge and Flechon, 1988). This would confirm that the descent of the embryos into the uterus 
might occur a few hours earlier in buffalo than in cattle. Compact morulae are observed from 125 to 
152 h post-oestrus and blastocysts from 141 hours. For this reason, it is reasonable to anticipate the 
flushing in buffaloes on day 6 rather than on day 7 as usually performed in cattle. 
 
Embryo collection 
When the flushing is completed, the cuff is deflated and the contents of the catheter are carefully 
allowed to flow into a sterile holder located at the end of the outflow tubing. Usually, an embryo 
filter is located at the end of the Fooley catheter so that the flushed medium can be decanted and 
subsequently filtered. The filtered medium is dispensed into a search dish with grid and visualized 
using a stereoscope (dissecting microscope) at 10× magnification. All embryos are transferred to a 
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clean Petri dish containing holding media with higher concentrations of FBS/FCS (10%–20%) or 
BSA (0.4%). Embryos are then visualized at a higher magnification (40–60×) and classified 
according to their morphology, stage of development (unfertilized oocytes, early morula, tight 
morula, blastocyst, expanded blastocyst, hatched blastocyst), and quality (excellent, good, fair, poor 
and degenerate) (Stringfellow and Seidel, 2007). The quality score is based on morphologic 
assessment of the physical integrity of embryos and morphologic characteristics according to the 
stage of embryonic development, compaction status, colour of cytoplasm, areas of cellular 
degeneration, number of extruded blastomeres, size of perivitelline space, and the size and sphericity 
of the embryo. Only embryos classified as fair, good, or excellent should be transferred. Gandolfi 
(1997) showed that in vivo produced embryos are characterized by higher resistance to 
cryopreservation compared to the in vitro counterparts, probably because they develop into a natural 
environment. Embryos are kept in holding media after being “washed” at least three times into 
different, clean wells containing holding media (Stringfellow and Seidel, 2007). This procedure is 
recommended by the International Embryo Technology Society because a good washing could 
remove cellular debris and potential pathogens adhered to the zona pellucida. Embryos are kept in 
holding media at room temperature until they are transferred to recipients or prepared for freezing 
(Stringfellow and Seidel, 2007). This allows overcoming the problem of not being able to 
synchronize an adequate number of subjects as recipients (Neglia, 2006). In fact, it has to be 
underlined that embryo recipients need to be in the same stage of the oestrus cycle of the donor: the 
variability in terms of response to MOET does not allow to foresee the number of animals that have 
to be synchronized. 
 
Factors affecting MOET efficiency in buffalo 
Superovulatory response in buffalo could be affected by intrinsic and extrinsic factors. Intrinsic 
factors, known to influence the response to MOET, are the age of the donors, the stage of the 
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oestrous cycle, the steroid profile, the presence of the dominant follicle at the start of treatment and 
genetic factors. Among the extrinsic factors, the MOET schedules, the source of hormones, as wells 
as season, nutrition, days in milk etc. affect the efficiency. 
 
Intrinsic Factors 
 
Age of the donor 
Since the bovine follicular population is inversely related to age (Erickson, 1966), several authors 
have suggested that the age of the donor would influence the superovulatory response and the quality 
of embryos (Gordon, 1975; Du-Mesnil Du-Buisson et al., 1977). In buffalo, heifers show better 
response to MOET in terms of ovulations and recovery rate than pluriparous cows (Zicarelli, 1997), 
but a high incidence of unfertilized oocytes (UFO) is recovered. This could be due to the difficulty in 
establishing their sexual maturity, for the large variability of the population (Zicarelli, 1997). The 
high recovery of UFO after MOET treatment may be hence explained by a failure related to the time 
of fertilization, due to incompetent oocytes or not capacitated sperm, or moreover to an inadequate 
uterine environment. In addition, the reproductive apparatus in buffalo has lower dimensions than the 
bovine counterpart (Vittoria, 1997): if the animals do not show an adequate uterus development, it 
could be difficult performing the flushing. In any case, no differences have been shown in animals of 
different age or parity in terms of embryo recovery (Misra and Tyagi 2007). 
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Stage of the oestrous cycle 
As the number of follicles responsive to exogenous gonadotropins varies during different stages of 
oestrous cycle, the stage of cycle is one of the most important sources of variability in determining 
the superovulatory response. Although superovulatory treatment has been initiated during various 
stages of oestrous cycle, the greatest superovulatory response is reported when superstimulatory 
treatments are initiated 8 to 12 days after oestrus, in correspondence with the emergence of the 
second follicular wave (Alexiev et al., 1988; Misra et al., 1994). Similar results in terms of embryo 
recovery rate are reported when MOET treatment is initiated between days 12 and 15 after oestrus 
(Misra et al., 1990). Although the day of emergence of the second wave differ between buffaloes 
with two or three waves/cycle, this condition does not seem to be mandatory to improve MOET 
response in buffalo, since superovulated animals with 2 or 3 follicular waves (Heleil and El Deeb, 
2010) show similar number of follicles (7.50 vs. 7.33), ovulations (5.81 vs. 6.08), corpora lutea (3.94 
vs. 4.42), recovered embryo + ova (2.69 vs. 2.69) and transferable embryos (1.06 vs. 1.17). 
Moreover, because of the large variability in terms of oestrus duration in buffaloes, the prediction of 
ovulation can hardly be achieved (Baruselli et al., 1997; Campanile et al., 2010). Nasser et al. (1993) 
have shown that the superovulatory response is definitely higher when gonadotropin treatments are 
initiated precisely at the time of follicular wave emergence rather than 1 or 2 days before or later, 
making it necessary to synchronise the timing of follicular wave emergence. More recently, Jiang et 
al. (2006) observed that, in buffaloes, the initiation of the treatment on days 7 to 8 seems to give 
higher superovulatory response compared to days 9 to 10 or 13 to 14. 
 
Progesterone levels during MOET treatment 
If the stage of the oestrus cycle when starting the MOET protocol is not yet well defined, the 
influence of progesterone on superovulatory response is ascertained. Although a former study failed 
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to establish a correlation between progesterone concentration on the day of FSH treatment and 
superovulatory response (Ullah et al., 1992), a positive correlation between superovulatory response 
and circulating progesterone levels at the time of gonadotropin treatment has been demonstrated in 
both cattle (Goto et al., 1988) and buffalo (Misra et al., 2000; Madan, 1996). In agreement with this, 
it has been proven in vitro by Park et al (1996) that progesterone is able to act on the β-subunits of 
the pituitary gland, by inducing LH secretion and storage in rat. Furthermore, in vivo progesterone 
decreases the frequency of GnRH pulses secreted into the hypothalamic–hypophyseal portal 
circulation (Karsch et al., 1987). Since GnRH is also an important regulator of the number of GnRH 
receptors, it is hypothesized that progesterone could decrease pituitary responsiveness to GnRH by 
reducing the frequency of GnRH pulses which in turn would lead to reduced synthesis of GnRH 
receptors (Nett et al., 2002). Therefore, progesterone high levels during the first days of 
superovulation treatment may increase LH storage in pituitary gland and increase GnRH induced LH 
release (Nett et al., 2002). Buffaloes with more than 2 ng/mL plasma progesterone levels show better 
superovulatory response compared to those with less than 2 ng/mL, although the presence of a 
functional corpus luteum has been recorded (Madan et al., 1988). The administration of exogenous 
progesterone by intravaginal device can also be used to ensure high progesterone levels on the day of 
starting MOET treatment (Neglia et al., 2010), resulting in a higher number of corpora lutea and 
recovered embryos on day 6 post-oestrus (flushing). 
 
Presence or absence of dominant follicle  
Assessment of follicular status prior to the initiation of a superovulatory treatment may be important 
for improving the superovulatory response. During a normal follicular wave, the decreasing 
concentrations of FSH, caused by the secretions of the cohort but especially by the dominant follicle 
(oestradiol and inhibin), lead to the regression of the subordinate follicles. Therefore, gonadotropin 
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treatments should initiate at the time of follicular wave emergence, optimizing the number of follicles 
that can be recruited. The presence of a dominant follicle on the day of starting MOET schedule 
significantly influences embryo recovery rate, reducing the number of follicles that can be recruited 
and increasing the incidence of those that are encountering atresia. Italian Mediterranean buffaloes 
that underwent MOET in the absence of a dominant follicle show higher recovery rate (3.0 vs. 1.87, 
in absence or presence of dominant follicle, respectively) and number of transferable embryos (2.92 
vs. 1.74, in absence or presence of dominant follicle, respectively), than those superovulated in its 
presence (Zicarelli, 1997). The influence of dominant follicle is still not clear in Murrah buffaloes. A 
study carried out by Taneja et al (1995) showed no differences in terms of serum progesterone 
concentration, recovery rate or transferable embryos, but a higher number of corpora lutea on the day 
of flushing in the absence of a dominant follicle. In another study, despite a similar number of 
corpora lutea and embryos, a higher number of large follicles was recorded regardless of the presence 
or absence of a dominant follicle during the MOET treatment (Manik et al., 1998). It is possible to 
hypothesize that these discrepant results may result from a difference in the functional status of the 
dominant follicle at the beginning of the superovulatory treatment. Ginther et al (2001) highlight that 
during a normal follicular wave the dominant follicle has a growth phase, followed by a static and 
regression phases. Clearly, the beginning of MOET treatment during one of these phases could result 
in different response, due to the different activity of the dominant follicle on the subordinates. 
Moreover, in cattle the number of follicles of 3 to 8 mm in diameter is highly correlated with the 
absence of a dominant follicle, detected by a single ultrasound examination (Bungartz and Niemann, 
1993). The number of small and medium follicles prior to initiation of superovulation in buffaloes is 
not always different between subjects that show and those that do not show a dominant follicle 
(Manik et al., 1998). Therefore, it can be concluded that the use of morphological criteria, based on 
the size of the largest follicle alone, are not sufficient to predict the response of buffalo to MOET. 
Numerous methods have been used to remove the influence of the dominant follicle. Previously it has 
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been specified that MOET is normally carried out in presence of progesterone releasing intravaginal 
device, with or without oestradiol. If it is possible to use oestradiol (forbidden in many countries), it 
should be administered before initiating treatment by progesterone releasing intravaginal device, 
causing the regression of the dominant follicle (Baruselli et al., 1999). In countries where oestradiol 
cannot be used, practitioners have turned to alternative treatments for the synchronization of follicle 
wave emergence, such as mechanical follicle ablation or the administration of GnRH to induce 
ovulation. High progesterone levels suppress follicular growth, maintaining a high number of small 
follicles on the ovary when MOET treatment is initiated. 
 
Genetic factors  
There are two main types of domestic buffalo: the River buffalo of the Indian subcontinent with 50 
pairs of chromosomes and the Swamp buffalo of the South Asian region with 48 pairs of 
chromosomes. Crossbreeding by mating River and Swamp buffalo has been done in many countries. 
This mating produces a hybrid F1 with a chromosome complement of 2n = 49. Slight differences 
have been observed after SO in these three genotypes. Usually, crossbred and Swamp buffaloes show 
a lower ovary diameter compared to the River, although this is not a good indicator to predict the 
number of embryos collected. In fact, both the number of corpora lutea and embryos are not different 
among the three genotypes (on average 6 corpora lutea and 2-2.7 embryos/donor) (Situmorang et al., 
2003). Genetic factors have to be considered in terms of individual differences among subjects. It is 
reported that cows and buffaloes which respond poorly to first superovulation treatment have 
tendency to respond poorly to subsequent superovulation, while those which respond well to first 
superovulation continue to do so during subsequent treatments (Moor et al.,1985, Zicarelli, 1997). 
Probably the reason for such variations could be due to genetic constitution of a donor that may have 
more or less sensitivity to exogenous gonadotropins. This conclusion is substantiated from the reports 
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that Booroola Merino and Cambridge sheep are known for high prolificity and Booroola gene in 
these sheep has been shown to be associated with higher superovulatory response (Bindon et al., 
1986). Similarly, beef breeds are reported to be more sensitive to eCG stimulation than dairy breeds 
(Mariana et al., 1970; Sreenan and Beehan, 1976). Some studies have shown that IGF-1, the main 
receptor of IGF, is involved in some physiological processes, including ovarian follicular 
development (Mazerbourg et al., 2003; Beg and Ginther, 2006), ovulation (Echternkamp et al., 2004), 
pre-implantation embryo development (Velazquez et al., 2009), conception and growth. These 
reports concluded that oocyte quality and embryo viability are associated with blood concentrations 
of IGF-1 in domestic ruminants undergone superovulation treatments. 
 
Extrinsic Factors  
 
MOET schedules and different types of gonadotropins 
Three different types of gonadotropins from various sources have been used to induce 
superovulation:  
Equine chorionic gonadotropin (eCG), or pregnant mare serum gonadotropin (PMSG), is a 
complex glycoprotein with both FSH and LH activity (Murphy and Martinuk, 1991) that has been 
largely used to induce SO because of its low cost and easy availability. In cattle, eCG induces 
follicular growth primarily due to its FSH like activity by preventing or reversing the process of 
atresia in ≥ 1.7 mm diameter follicles and thereby increasing the number of follicles capable of 
responding to the gonadotropin (Moor et al., 1985). Its main characteristic is the long half-life that is 
about 40 hours in cattle, persisting in the circulation until 10 days after the end of the superovulation 
treatment. On one hand, a single eCG administration is enough to ensure an optimal superovulatory 
31 
 
response, facilitating animals’ management and handling, on the other hand the prolonged high eCG 
circulating levels can be associated with ovarian hyperstimulation, further growth of extra follicles 
after ovulation, abnormal endocrine profiles and high incidence of anovulatory follicles (Karaivanov 
et al., 1987). Indeed, after eCG treatment some follicles tend to luteinize and others develop in cysts, 
rather than ovulate (Monniaux et al., 1983) altering the oestradiol: progesterone ratio. Moreover, 
consequent to luteinisation of some of the rescued follicles, elevated concentration of P4 at the time 
of LH surge may account for asynchrony of the LH surge leading to impaired transport of gamete in 
the fallopian tube and poor fertilization rate (Mapletoft and Murphy, 1993). In contrast, a study 
demonstrated that high progesterone levels (more than 2.3 ng/mL) on the day of eCG administration 
seem to be associated with higher embryo recovery (Heleil and El Deeb, 2010). In addition, eCG 
treatment in buffaloes results in elevated plasma inhibin from fully developed follicles which 
continue for a long time and culminate in the inhibition of FSH, leading to poor ovulation in the 
remaining follicles (Singh et al., 2000). One limitation with eCG is that its FSH/LH activity varies 
not only among pregnant mares, but also among bleedings in the same mare collected at different 
times during gestation (Gonzales-Mencio et al., 1978). Since hormone concentration could be 
different at different times of gestation and, hence, among different batches, there is variability in 
terms of superovulatory response and embryo recovery. In buffalo, the treatment schedule consists in 
the intramuscular injection of dosages variable between 2,500 to 4,000 IU, however, 3000 IU of eCG 
by intramuscular route is commonly practiced (Karaivanov et al., 1990). A schematic representation 
of eCG treatment is shown in Fig. 3.  
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Figure 3. The eCG superovulatory protocol. 
 
Mean embryo recovery rate is between 0.7 (Karaivanov et al., 1987) and 2 (Schallenberger et al., 
1990; Heleil and El Deeb, 2010) embryos. The ovarian response to eCG treatment has also been 
tested on pre-pubertal buffalo heifers in association with GnRH (Singh and Madan, 1999), reporting 
a mean number of 4.5 to 5 ovulations/heifer, suggesting that the embryo recovery would be similar 
from that reported in adult buffaloes. Furthermore, GnRH administration has no influence on the total 
ovulation rate, although it allows a reduction in the interval between the first and the last ovulation 
(about 20 hours compared to 40 in GnRH treated and control buffaloes, respectively). Attempts have 
been made to overcome the side effects of the long half-life of eCG by the intravenous injection of 
antibodies (polyclonal or monoclonal) to eCG at the time of the first insemination, 12 to 18 hours 
after the onset of oestrus (Fig.4). 
 
Figure 4. Use of antibodies during the eCG superovulatory protocol. 
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However, results are conflicting because of considerable variation in the interval between the 
injection of PGF2α and LH peak and also because of variation in the interval from the time of first 
standing heat to the LH peak (Dieleman et al., 1993). Treatment with Neutra-eCG results in a 
significant decrease in the peripheral inhibin concentration at 84 to 120 hours after prostaglandin and 
in the number of large anovulatory follicles at 168 hours, although the number of large follicles is 
lower than that recorded in buffaloes treated by eCG alone (Palta et al., 1997) and no differences in 
terms of corpora lutea number is recorded. Furthermore, embryo recovery rate by using antibodies 
versus eCG is about 1.51/donor, with 1 transferable embryo/donor, thus similar to that obtained with 
eCG alone (Palta and Madan, 1995).  
Pituitary extracts of FSH and LH have given a better superovulatory response compared to other 
gonadotropins and therefore they have been more widely used for buffalo MOET. The two most 
commonly used commercial FSH preparations are made from porcine pituitary extracts and have 
some LH activity which varies between manufacturing batches (Chupin et al., 1984). Although high 
amounts of LH in FSH preparations interfere with optimal superovulatory response, it is believed that 
a low level of LH contamination does not interfere and may even be needed for superovulation 
(Herrier et al., 1991). In any case, the maximum acceptable level of LH contamination in pituitary 
extract for SO would range between 15 and 20%. This variability may be reduced by using bovine 
FSH produced by recombinant DNA technology (Looney et al., 1990). However, no trials have been 
performed till now in buffalo species. The mechanism of this inhibitory effect of LH contamination is 
not clearly known, however, it is postulated that elevated LH may disrupt the balance of androgen 
and oestrogen production necessary for the prevention of atresia in follicles (Farookhi, 1981) or LH 
may induce down-regulation of its receptors on theca and/or granulosa cells (Murphy et al., 1984). 
Because of its short half-life, pituitary extracts are administered twice a day, usually for schedules of 
3 to 5 consecutive days (Fig. 5).  
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Figure 5. Superovulatory protocol based on pituitary extracts. 
 
 
Usually the administration of a decreasing dosage is preferred, to increase follicular recruitment and 
development. Regimens with constant, decreasing or increasing dosages have been used (from 800 to 
1200 IU), although no differences have been recovered in terms of embryo recovery (Zicarelli, 1997). 
In buffalo, dosages lower than 700 IU of FSH are not able to induce a good response. Moreover, it 
has to be considered a further increase or decrease of about 20%, if buffaloes weighing more than 
800 kg or heifers are treated, respectively. Several attempts have been done in cattle in order to 
reduce the number of FSH administrations, by injecting the hormone together with some slow 
releasing substances (e.g. PVP or hyaluronic acid) subcutaneously or intramuscularly (Hill et al., 
1985; Biancucci et al., 2016). However, a single injection seems to result in lower response to MOET 
compared to multiple dose injection regimens (Misra and Tyagi, 2007). However, embryo recovery 
rate is similar to that reported for treatment by eCG, varying from 0.9 to 3.5 embryos or ova/donor 
(Zicarelli, 1997; Baruselli et al., 1999; Carvalho et al., 2002; Neglia et al., 2010). Mediterranean 
buffaloes treated for MOET by a commercial pituitary extract preparation (Zicarelli, 1997) responded 
with 1.9 embryo/donor (and only 1.51 transferable embryos). 
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Human menopausal gonadotropin has also been used to induce MO, with results similar to those 
obtained by pituitary extracts (Filicori et al., 2003). However, commercial hMG preparations are 
highly expensive and are scarcely utilized in practice. 
 
Influence of the season 
The season may influence the superovulatory response of buffaloes for both seasonality and weather 
conditions. It is known that buffalo is a short day breeder, that tends to increase its reproductive 
activity when day light hours decrease (Campanile et al., 2009) because of its tropical origins. 
Indeed, they originate from North equatorial areas, where the availability of forage coincides with the 
period in which dark hours increase. Therefore, it has been supposed that only the animals calving in 
the most suitable period for survival of the offspring were selected (Zicarelli, 1974). This 
characteristic was retained even when they were transferred to places where forage is always (Italy) 
or less (South Equator areas like Sao Paulo, Br) available. In fact, in Italy, buffalo shows its 
maximum reproductive efficiency in the autumn-winter period, in which daily light hours are lower 
(Campanile et al. 2010). Therefore, it is reasonable that the application of reproductive 
biotechnologies would also be more successful in this period. In contrast, embryo recovery rate after 
MOET in periods of decreasing daylight length was lower compared to other periods of the year 
(Zicarelli et al., 1993), likely because in this period also hypofertile buffaloes are cycling and hence 
are enrolled for SO, leading to low efficiency (Zicarelli, 1997). Since only cycling subjects are 
selected for superovulation, the application of treatments out of the breeding season allows to select 
high fertile subjects, that are able to show high reproductive activity also when day light hours 
increase. The influence of extreme weather conditions in tropical countries on the superovulatory 
response in buffalo is controversial. In fact, although an effect of high temperature and high humidity 
have been reported (Misra, 1993; Mutha et al., 1994), it is known that because of its tropical origin, 
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buffalo does not undergo heat stress like cattle. It is likely that the daily light length rather than 
weather conditions influences the superovulatory response. 
 
Days open 
Another factor that could affect the response to MOET treatment is the number of days open 
(Zicarelli et al., 1993). Zicarelli (1997) reported that the higher superovulatory response, together 
with both the higher number of transferable embryos per donor and higher transferable 
embryos/corpora lutea ratio were obtained from animals between 61 and 220 days post-partum. 
Buffaloes that undergo MOET schedules within 60 days post-partum produce mainly unfertilized 
oocytes, probably for inadequate uterine environment for sperm survival or inadequate oocyte 
competence. While the lack of response in buffaloes at more than 220 days post-partum could be due 
to uterine inflammations or deep anoestrus, phenomena that these subjects encounter when they are 
not pregnant for long time (Zicarelli, 1997). 
 
Influence of nutrition 
Nowadays, the influence of nutrition on reproductive efficiency is well established (Campanile and 
Neglia, 2004), although some mechanisms remain to be understood. For optimum superovulatory 
response a donor should be on a well-defined plane of nutrition. Diets characterized by low starch 
content (<15.5%) and high cellulose content (>23%) allow to obtain the maximum superovulatory 
response in buffaloes treated by FSH (Di Palo et al., 1994). This is particularly evident in buffaloes 
within 120 days post-partum, thus during the catabolic phase of lactation, when the animals 
encounter the negative energy balance. This interesting observation is supported by the evidence that 
diets characterized by low energy density result in an increase of small follicles and high quality 
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oocytes (Campanile et al., 1999) improving blastocyst yield in vitro (Di Palo et al., 1994). 
Consequently, the utilization of high quality forages (with high nutritive value and relatively low 
crude fibre level), and low concentrates content in the diet is recommended (Zicarelli, 1997): these 
types of diets meet nutritional requirements, without impairing reproductive efficiency. Furthermore, 
meeting nutritional requirements is fundamental in order to ensure a proper body condition score 
(BCS), that was demonstrated to affect the reproductive efficiency (Baruselli et al., 2001). The BCS 
system is a scoring method of evaluating the energy reserves of dairy animals which provides a better 
understanding of biological relationships between body fat, milk production and reproduction 
(Anitha et al., 2010). In buffalo, body condition score (BCS) is known to affect fertility; in fact, 
pregnancy rate improved from 39.7, 53.9 and 56.7% with the improvement of BCS from 3.0 to 3.5 
and 4.0, respectively (Baruselli et al., 1999). A lower BCS is responsible for lower LH pulsatility, 
impairing the efficiency of reproductive biotechnologies, such as AI and MOET. 
 
r-BST priming 
To increase the response of the follicular population to MOET treatment, recombinant bovine 
somatotropin (r-BST) priming has been used in both cattle (Gong et al., 1993) and buffalo 
(Songsasen et al., 1999). Recombinant bovine somatotropin acts increasing the concentration of 
Insulin-like Growth Factor I (IGF-I) together with FSH, increasing both the number of small follicles 
(Gong et al., 1997) and the number of LH receptors on the granulosa cells and improving follicular 
growth and oocyte. Moreover, IGF-I promotes cumulus cells expansion (Izydar et al., 1998) and this 
can contribute to oocyte adhesion to the fimbriae after ovulation (Carvalho et al., 2007). In buffalo, 
results on r-BST influence during superovulation are controversial. Treatment with r-BST in Swamp 
buffalo increased the number of corpora lutea and recovered ova and significantly the number of 
transferable embryos (Songsasen et al., 1999), leading to a mean recovery rate of about 3 transferable 
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embryos/donor. Similarly, a study of Zicarelli (1994) showed that superovulated Mediterranean 
buffaloes treated with r-BST showed a lower incidence of ovarian cysts and higher recovery rate, in 
terms of both recovered ova and transferable embryos. However, the dosage utilized seems to affect 
the superovulatory response. Good results have been obtained by using 250 mg, administered on the 
day of progesterone releasing device insertion (Day 0) and starting the superovulation schedules on 
both day 4 (Carvalho et al., 2007) or day 9-11 (Songsasen et al., 1999). In contrast, contradictory 
results are reported with the use of 500 mg, since in some studies a great improvement in terms of 
ovulation rate and embryo recovery was reported (Baruselli et al., 2003), whereas no effect was 
observed in others (Carvalho et al., 2007).  
 
Ovum Pick-up (OPU) priming  
OPU technology allows the visualization and the aspiration of all follicles with diameter >2 mm, 
which resets the oestrous cycle and avoids the dominance of one follicle over the subordinates. In 
most of the species the optimal interval between aspiration sessions is 3–4 days (Galli et al., 2001), 
but in buffaloes higher intervals may be necessary (Neglia et al., 2011). For this reason, with this 
technology, it is hypothetically possible to avoid the atresia of subordinate follicles and increase the 
follicular waves from 2-3 to 6 for each cycle. This leads to the collection of a higher number of 
cumulus oocyte complexes usable for in vitro embryo production (IVEP), as well as to an improved 
oocyte quality (Galli et al., 2001). Moreover, OPU priming can be utilized to reset follicular 
population before initiating superovulatory treatment, avoiding the negative influence of the 
dominant follicle on the subordinates and improving oocyte quality. Zicarelli et al (1995) have shown 
that OPU priming in buffalo increases the number of animals able to respond with at least one 
embryo (more than 68% vs. 53%, in buffaloes undergone OPU priming and controls, respectively), 
and this is particularly evident during periods of decreasing daylight length (84 vs. 15%, in buffaloes 
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undergone OPU priming and controls, respectively). Furthermore, in the same period, OPU primed 
buffaloes showed a higher ova/corpora lutea ratio (47 vs. 12%, in buffaloes undergone OPU priming 
and controls, respectively) and transferable embryos (3.2 vs. 0.5, in buffaloes undergone OPU 
priming and controls, respectively). However, no differences were observed between buffaloes 
undergone OPU priming and the control counterparts during periods of increasing daylight length.  
 
Influence of interval between PGF and oestrus 
Another factor to take into account for a good superovulatory response is the interval between 
prostaglandin administration and oestrus. Usually more than 90% of animals exhibits oestrus within 
48 hours after PGF2α administration (Misra and Pant, 2003). Interestingly, these animals give higher 
recovery rate and number of viable embryos compared to those that exhibit oestrus later. Probably 
late oestrus signs could be associated with a delayed (or failure) ovulation and lack of oocyte 
fertilization. 
 
Repeated superovulation 
To obtain full benefits of non-surgical embryo collection, an elite donor should respond optimally to 
repeated gonadotropin treatment. Usually, it would be reasonable to carry out the hormonal treatment 
on the same subject at least 80 or 100 days apart, in cattle and buffalo respectively. First of all, it has 
to be considered the type of gonadotropin that is utilized. A study carried out by Cruz et al (1991) 
demonstrated that Swamp buffaloes, treated by eCG for four successive superovulatory treatment, 
undergo a high incidence of anovulatory large follicles (cysts) and reduced embryo recovery rate 
probably because of the long half-life of eCG and, consequently, the continuous ovarian stimulation. 
Therefore, the utilization of pituitary extracts is preferred. When buffaloes were treated repeatedly for 
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SO by FSH for six times 77 days apart, a marked decline (about 50%) in ovulation rate, corpora lutea 
and embryo recovery was reported (Mutha et al., 1994). However, it is worth pointing out that the 
repetitive superovulatory treatments up to the 6
th
 time did not significantly affect the fertility of the 
donors, since more than 80% pregnancy rate and about 1.8 services/conception after the last 
treatment were recorded. 
 
 Utilization of exogenous LH 
A study carried out by D’Occhio et al (1999) demonstrated an improvement in MOET treatment in 
cattle, obtained by using a GnRH agonist – LH protocol. This is based on the block of the 
preovulatory endogenous LH surge by treatment with a GnRH agonist bio implant, hence making 
ovulation possible only by the exogenous administration of LH after follicular superstimulation. The 
advantage of this protocol is that the ovulations occur over a relatively short and predictable period of 
time after LH administration (D’Occhio et al., 1997). It results in higher ovulation rate (about 70%) 
and higher embryo recovery rate (3.7 embryos on average) compared to subjects treated by a 
conventional MOET protocol or in those in which LH is administered 36 hours after the 
superovulatory protocol (Carvalho et al., 2002). A further improvement could be obtained by the 
incorporation of the oestradiol treatment at the start of the superstimulatory treatment: in this case it 
is likely that higher follicular responses and ovulation rate is recorded. 
 
Administration of prostaglandin on the day of artificial insemination 
Early return-to-oestrus of superovulated donors after embryo collection is necessary to improve 
efficiency of embryo production. If an administration of PGF2α or its analogues causes CL regression 
after days 5-6 till days 15-17 of the oestrous cycle, by increasing the intraluteal production of 
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vasoactive molecules, such as endothelin-1 (ET-1) and Angiotensin-II (Ang-II) (Ohtani et al., 1998; 
Hayashi et al., 2001), its role during the oestrous phase is still unclear. Ainsworth et al (1979) 
reported that inhibitors of prostaglandin synthesis inhibit ovulation and that the administration of 
PGF2α on the day of AI increases CL dimensions and progesterone production at the end of a 
standard (Ovsynch-TAI) synchronization treatment in buffalo (Neglia et al., 2008), probably via ET-
1 and Ang-II gene expression inhibition (Girsh et al., 1996; Meidan et al., 1999;  Miyamoto and 
Shirasuna, 2009). Moreover, the stimulation of α-receptors in the ampulla and fimbriae by 
prostaglandins increases the contractility of smooth muscle, thus affecting gametes transportation 
(Riehl and Harper, 1981). Probably, the influence of prostaglandin during the ovulation could be due 
to its action during follicular rupture. Indeed, the ovulatory process involves a complex series of 
biochemical and biophysical events that ultimately lead to the rupture of the preovulatory follicle and 
the release of the maternal germ cell into the oviduct. The LH peak results in the activation of a novel 
form of cyclooxygenase (COX-2) enzyme, in the granulosa cells of the preovulatory follicle (Hedin 
et al., 1987), increasing the intrafollicular concentrations of prostaglandin F2α and E2 and these are 
responsible for the increased contraction of the myoid (smooth muscle) components of the ovary, 
leading to ovulation (Senger, 2005). To verify the possibility of increasing oocyte capture by the 
fimbria, the administration of prostaglandin F2α during the peri-ovulatory period has been also 
utilized during superovulatory treatment (Soares et al., 2013). A higher number of ova (3.5 vs. 2.3, in 
buffaloes treated with prostaglandin and not treated, respectively) and transferable embryos (2.7 vs. 
1.8, in buffaloes treated with prostaglandin and not treated, respectively) was recovered in buffaloes 
treated with 4 doses of prostaglandins 12 hours apart, starting from the end of the superovulatory 
treatment. This is probably due to both: 1) improved contractions of the follicular wall, which then 
ruptures, expelling the ovum and accompanying follicular fluid containing high levels of PGF2α into 
the tubal ampulla (LeMaire and Marsh, 1975) and 2) increased contractile activity of the tubes. In 
fact, it is believed that elevated PGF2α levels in the follicular fluid are necessary to enhance ovum 
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capture by tubal fimbriae. In addition, the increased contractility of the oviductal smooth muscles, 
results in increased speed of embryonic transport and development (Weber et al., 1991; Kissler et al., 
2004). 
 
Immunisation against inhibin 
Despite an equal number of ovarian follicles recruited in a cohort wave in buffalo and cattle 
(Baruselli et al., 1999; Campanile et al., 2010; Mapletoft and Bó, 2012), the number of recovered 
embryos in the former is very low. The developing dominant follicle produces inhibin, a substance 
that inhibits both pituitary FSH secretion and follicular development of subordinates. The 
immunoneutralisation against inhibin in cattle stimulates follicle development (Medan et al., 2004), 
embryo yield (Mantovani et al., 1997) and embryo quality (Li et al., 2009), reducing the phenomenon 
of follicular atresia. The immunisation against inhibin improves superovulatory response also in 
water buffaloes (Li et al., 2011), in terms of improving superovulation rates and number and 
percentage of transferable embryos, as well as elevating plasma E2 concentrations during oestrus and 
P4 concentrations during diestrus. In particular, the utilisation of primary immunisation with 2 mg 
inhibin fusion protein is able to increase the ovulation rate (6.5 vs 4.8, in treated and not treated 
animals, respectively), the number of recovered ova (4.5 vs. 2.8, in treated and not treated animals, 
respectively) and the number of transferable embryos (3.3 vs. 1.6, in treated and not treated animals, 
respectively). On the other hand, as described above, the utilization of antibodies anti-eCG reduces 
peripheral inhibin concentration and the number of anovulatory follicles (Palta et al., 1997), slightly 
improving the superovulatory response. 
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Causes of poor embryo recovery rate in superovulated buffaloes 
As reported in the introduction of this chapter, several attempts have been performed to optimize the 
MOET technique in buffalo species. However, although embryo recovery improved in the last thirty 
years, from less than 1 viable embryo to 2.5-3/donor, the MOET typically results in a relatively low 
recovery of both embryos and unfertilized ova in buffalo (Zicarelli 1997; Misra and Tyagi, 2007; 
Alexiev et al., 1988 Misra et al., 1994; Madan et al., 1996; Neglia et al., 2010; Taneja et al., 1995; 
Palta et al., 1997; Baruselli et al., 1999; Carvalho et al., 2002; Misra and Pant, 2003; Beg et al., 1997; 
Qin et al., 2012) compared with cattle (Mapletoft and Bó, 2012; Bó and Mapletoft, 2014) throughout 
the world. In addition, while in cattle 88% of subjects produced at least 1 embryo after 
superstimulation, the proportion of responsive buffaloes varies between 30 and 50% (Zicarelli, 1997). 
Several hypotheses have been formulated to explain the low embryo recovery recorded in buffalo 
species after SO. It is known that oogenesis in cattle and buffalo gonads starts during the foetal life, 
resulting in the formation of a pool of primordial follicles, which represents the source of gametes 
throughout the life of the female. The number of primordial follicles represents the first great 
difference between cattle and buffalo. In fact, while in cattle the number of primordial follicles from 
the birth to about 4
th
 year of life is 133,000 (Erickson, 1966; Driancourt et al., 1993), only 26,600 (Ty 
et al., 1994) or 40,000 (Samad and Nasseri, 1979; Danell, 1987) primordial follicles have been 
recorded, in Swamp and River buffaloes, respectively. Therefore, if buffaloes have about 20-30% of 
the total pool of primordial follicles compared with cattle, it would be reasonable that the response to 
SO treatment in terms of embryo recovery in the former is about 1/5 compared to the latter.  
However, since the response of buffalo in terms of follicles > 1cm at the end of the MOET treatment 
is quite satisfactory, this hypothesis leaves some doubts. Some studies (Baruselli et al., 1999; 
Carvalho et al., 2002; Neglia et al., 2010) demonstrated that superovulation schedules usually result 
in the growth of a high number of ovulatory follicles, together with a relatively high ovulation rate 
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(50-70%), although embryo/ova recovery rate is very low (13-35%). Therefore, it has been supposed 
that a limited capacity for follicular growth and ovulation may not be the causes of the relatively low 
embryo recovery recorded in superovulated buffalo. It is more likely that the recruitment of the 
oocytes by the fimbriae and/or the transport of ova and embryos within the oviduct are compromised 
(Carvalho et al., 2002). Plasma 17-β-oestradiol (oestradiol) levels recorded in buffaloes are lower 
than those reported in cattle during normal oestrus cycles (Batra and Pandey, 1983). On the contrary, 
oestradiol plasma concentrations are particularly high during SO (Beg and Ginther, 2006), resulting 
in an altered oestradiol: progesterone ratio, that may influence oocyte recruitment by the fimbriae 
(Misra et al., 1998). This would be further confirmed by the negative correlation observed between 
the presence of a high number of large (>8 mm) follicles on the day of embryo recovery and the 
number of recovered embryos (Misra et al., 1998; Baruselli et al., 1999). Furthermore, it is worth 
noting that the quality of the oocyte and especially the cumulus cell layers surrounding it are factors 
that may affect oocyte capture by the fimbriae (Priedkalns, 1987). Grade I and II oocytes (those 
surrounded by several granulosa cell layers) represent only about 50-60% (Neglia et al., 2011) of the 
total, whereas about 80% is recorded in cattle. 
In conclusion, the application of MOET in buffalo still needs to be improved, to increase both the 
number of subjects that are able to produce at least one embryo and, possibly, the number of 
recovered embryos. 
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Aim of the work 
 
The main objective of this thesis was to investigate the different factors affecting the embryo 
recovery in superovulated buffaloes. Several hypotheses have been formulated over the years to 
explain the low embryo recovery recorded in this species after superovulatory treatment, among 
which the most likely is a failure of ovum capture.  
Before addressing the major issue, other experiments were carried out in order to select both the 
donors and the most suitable superstimulation treatment. Indeed, another critical factor limiting the 
application of this technology in buffalo is the high between-animal variability in the number of 
embryos produced (Govignon et al., 2000; Gasparrini et al., 2014). It was recently reported that 
follicular recruitment is predetermined within each individual, suggesting the possibility to select 
good donors (Neglia et al., 2011; Gasparrini et al., 2014). Therefore, the aim of Experiment 1 was to 
evaluate whether the Anti-Mullerian hormone (AMH) can be used as a reliable marker to select good 
embryo donors in addition to the screening of the antral follicular count, before enrolling buffaloes in 
embryo production programs. In order to do so, the association between AMH concentration in both 
plasma and follicular fluid and the antral follicular count was evaluated and the reproductive 
parameters, including AMH concentration and gene expression in granulosa cells, were compared 
between good and bad donors (≥ 12 and < 12 follicles, respectively). Another objective was to 
investigate the population of AMH-producing antral follicles in buffalo ovaries by determining AMH 
concentration in follicular fluid recovered from different size follicles and evaluating the mRNA 
expression profiles of development-related genes in the corresponding granulosa cells.  
With regard to the MOET treatment, as the follicular development switches from FSH-dependence to 
LH dependence after deviation, in order to better mimic the follicular dynamics in superovulated 
animals, FSH should be given first to ensure follicular growth, followed by LH administration at the 
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time of presumptive follicular deviation. This approach, that can be achieved by using eCG during 
the final stages of follicular growth, has never been investigated in buffalo. Therefore, the aim of 
Experiment 2 was to evaluate the efficacy of replacing the last four FSH injections with a single 
administration of 1000 IU of eCG compared to the conventional FSH decreasing superovulation 
protocol in Italian Mediterranean Buffalo. The efficacy of the two treatments was assessed by 
evaluating the follicular dynamics, as well as the number of corpora lutea and embryo yields.  
As previously stated, the main aim of this thesis was to analyse at different levels the various factors 
involved in the failure of ovum capture, as an improved knowledge may allow the development of 
strategies to improve the embryo recovery rate in superovulated buffaloes. Thus, in order to select the 
most reliable control group for the superovulation study, the aim of Experiment 3 was to evaluate the 
relationship between the ovarian follicular response at the start of an Ovsynch program and the 
pregnancy outcome. The results of this experiment allowed us to better plan the Experiment 4, by 
selecting the animals that ovulated after the 1
st
 GnRH as a control group to compare with 
superovulated animals. Finally, the aim of Experiment 4 was to compare the morphological 
parameters of the follicles and the steroid profile (progesterone and oestradiol) both in plasma and 
follicular fluid in the peri-ovulatory period in superovulated vs synchronized buffaloes. Furthermore, 
to investigate whether the failure is linked to lack of capture, the oocyte morphology and expansion, 
as well as the mRNA expression of gonadotropins receptors (FSHr and LHr) in granulosa cells were 
evaluated. In addition, the mRNA expression of factors playing a role on contraction-relaxation like 
ER1, PGR, VEGF and its receptors FLK1 and FLT1 was analysed in the oviduct. 
  
48 
 
EXPERIMENT 1 
 
Anti-Mullerian Hormone (AMH) concentration in follicular fluid and mRNA 
expression of AMH receptor type II and LH receptor in granulosa cells as 
predictive markers of good buffalo donors  
 
As previously mentioned, one of the most critical factors limiting the application of embryo 
technologies in buffalo is the high between-animal variability in the number of embryos produced 
(Govignon et al., 2000; Gasparrini et al., 2014). Moreover, the intrinsic species-specific lower 
number of primordial (Danell, 1987) and antral follicles (Van Ty et al., 1989; Baruselli et al., 1997) 
compared to cattle accentuates the problem of the high variability in follicular recruitment in this 
species. It was recently demonstrated that follicular recruitment is predetermined within each 
individual, allowing desirable and undesirable donors (Neglia et al., 2011; Gasparrini et al., 2014) to 
be distinguished, as in cattle (Tamassia et al., 2003). Therefore, in addition to the screening of the 
antral follicular count (AFC), identification of a reliable marker to select good embryo donors is 
fundamental before enrolling buffaloes in embryo production programs, to offset laboratory costs.  
Very recently, attention has focused on the anti-Mullerian hormone (AMH), a molecular marker of 
the ovarian follicular pool and follicular responsiveness to superovulatory treatments in women, 
cattle, goats and other species (Fanchin et al., 2005; Monniaux et al., 2010, 2011). The anti-Mullerian 
hormone is a 140-kDa glycoprotein that belongs to the transforming growth factor (TGF)-β family 
and is expressed only in the gonads (Cate et al., 1986). In cattle, as in other mammalian species, 
AMH is specifically expressed by ovarian granulosa cells (Vigier et al., 1984; Takahashi et al., 
1986); its expression is highest in granulosa cells of preantral and small antral follicles, and decreases 
during terminal follicular growth (Baarends et al., 1995), with low AMH concentrations found in the 
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follicular fluid of large antral and preovulatory bovine follicles (Monniaux et al., 2008). It is also 
known that AMH expression in granulosa cells and AMH concentration in follicular fluid are both 
low in atretic follicles (Rico et al. 2009). Anti-Mullerian hormone is known to play a critical role in 
folliculogenesis by modulating the FSH function and thereby limiting follicular recruitment (Weenen 
et al., 2004; Bentzen et al., 2013). In addition, AMH is a key mediator in regulating steroidogenesis, 
as it inhibits oestradiol secretion by reducing the expression of the aromatase enzyme CYP19 (Eilsø 
Nielsen et al., 2010) and progesterone production in granulosa cells in vitro (Yding Andersen et al., 
2008). Furthermore, AMH is negatively associated to the expression of LH receptors in small human 
antral follicles (Yding Andersen et al., 2008). The pattern of expression in the granulosa cells of 
growing follicles and the role in regulating folliculogenesis and steroidogenesis make AMH an ideal 
marker for the size of the ovarian follicle pool. Moreover, AMH has been shown to be a reliable 
endocrine marker of oocyte and embryo quality in humans (Lehmann et al., 2014; Lie Fong et al., 
2008).  
The only work carried out so far in buffalo reported a correlation between plasma AMH 
concentration and antral follicular count in Murrah heifers, suggesting that AMH is a potential 
marker of follicular reservoir in this species (Baldrighi et al., 2014). However, many aspects still 
need to be investigated to clarify the role of AMH in influencing follicular growth and oocyte quality 
in buffalo. Therefore, the aim of our study was to characterize the population of AMH-producing 
antral follicles in buffalo ovaries by determining AMH, concentration in follicular fluid recovered 
from different size follicles and evaluating the mRNA expression profiles of four follicular 
development-related genes (AMHR2, CYP19A1, FSHR and LHR) in the corresponding granulosa 
cells (GCs). Another objective was to evaluate whether AMH concentration in both plasma and 
follicular fluid (FF) and gene expression of granulosa cells are associated to the AFC. Furthermore, 
we compared reproductive parameters, including AMH concentration and gene expression, in good 
vs bad donors (≥ 12 and < 12 follicles, respectively). Finally, apoptosis-related genes, such as tumour 
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protein p53-inducible nuclear protein 1 (TP53INP1), and caspase 3 (CASP3) were assessed in 
granulosa cells from good and bad donors. 
 
Materials and Methods 
The Ethical Animal Care and Use Committee of the University of Naples Federico II (Naples, Italy) 
approved the experimental design and animal treatments.  
 
Experimental design 
The study was carried out in Southern Italy (latitude 40.5° - 41.5° N and longitude 13.5 - 15.5) during 
autumn, i.e. the breeding season, on 54 multiparous Italian Mediterranean Buffalo cows, with a mean 
weight and age of 565.3 ± 14.5 kg and 5.3 ± 0.3 years, respectively, over four replicates. To induce 
luteolysis and synchronize the occurrence of oestrus, buffaloes received a double administration of a 
PGF2α analogue (Cloprostenol, 0.250 mg/mL Schering-Plough Animal Health, Milan, Italy), spaced 
11 days apart and were slaughtered at a local authorized abattoir six days after the second 
administration, i.e. after the emergence of the first follicular wave but before development of a 
dominant follicle (Monniaux et al., 2008; Rico et al., 2011). The Ethical Animal Care and Use 
Committee of the University of Naples Federico II (Naples, Italy) approved the experimental design 
and animal treatments.  
On all animals AFC, recovery rate and oocyte quality were recorded, and both plasma and FF were 
collected for AMH determination. In a representative number (n=22) the mRNA expression of six 
genes (AMHR2, CYP19A1, FSHR, LHR, TP53INP1, and CASP3) was analysed in GCs. Finally, 
buffaloes were classified according to the AFC as good (≥ 12 follicles) and bad (< 12 follicles) 
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donors, in order to evaluate the differences in reproductive parameters. The criterion used to classify 
the donors was chosen on the basis of our previous experience on abattoir-derived ovaries during the 
favourable season.  
 
Collection of follicular fluid and granulosa cells 
At slaughter, ovaries were recovered individually and transported to the laboratory in physiological 
saline supplemented with 150 mg/L kanamycin at 30-35°C. All the ovaries were weighed and 
measured: ovarian size was assessed by measurement of two perpendicular diameters of each ovary 
with a millimetre scale. For each antral follicle, antrum size was estimated by measurement of two 
perpendicular diameters with a millimetre scale. Thus, all follicles with an antrum larger than 3 mm 
were counted (AFC) and allocated to three size classes: small (3-5 mm), medium (5-8 mm), and large 
follicles (> 8 mm). The FF of each follicle was aspirated by a syringe with a 21-gauge needle, poured 
into a petri dish for a quick search of the oocyte, recovered in a vial and centrifuged at 600 X g for 10 
min to separate the follicular fluid and the granulosa cells. After centrifugation, the FF recovered was 
directly snap frozen and stored at - 80°C until AMH determination, while the GCs-containing pellet 
was previously washed with PBS, centrifuged again at 600 X g for 10 min, then snap frozen in liquid 
nitrogen and stored at -80°C until RNA isolation. 
Small and medium follicles were respectively pooled (from 2 to 7 and 1 to 2 follicles, respectively) in 
each buffalo in order to get sufficient FF for AMH determination and GCs to isolate RNA. Follicular 
fluids from large follicles (> 8 mm) were recovered individually. 
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Evaluation of oocyte quality  
The FF recovered from different classes of follicles was inspected for the presence or absence of the 
cumulus-oocyte complex (COC) by microscope. The COCs recovered were scored for quality on the 
basis of morphological features, as previously described (Di Francesco et al., 2011). For each run, the 
recovery rate, i.e. the percentage of total number of COCs in relation to total number of aspirated 
follicles, and the percentage of superior quality oocytes (Grade A+B) were recorded. Briefly, 
according to our classification (Di Francesco et al., 2011), Grade A are oocytes with homogeneous 
cytoplasm and the entire surface surrounded by multiple layers of cumulus cells and Grade B those 
with homogeneous cytoplasm and with at least 70% of the surface surrounded by multiple layers of 
cumulus cells. 
 
Detection of AMH in follicular fluid and plasma 
Anti-Mullerian Hormone in follicular fluid was measured by a specific AMH Gen II ELISA kit 
according to the manufacturer’s instructions (Beckman Coulter, A73818, USA), as previously 
described for bovine species (Monniaux et al., 2008; Rico et al., 2009). Briefly, AMH was measured 
on 20 μL follicular fluid diluted at 1:100 for small follicles, 1:10 for medium follicles, and not diluted 
for large follicles. Each sample was run in duplicate in this study. The intra-assay and inter-assay 
coefficients of variation were <5% and <10%, respectively. For validation of the assay in buffalo, 
serial dilutions of different buffalo follicular fluids were analysed using the kit. The follicular fluid 
dilution curves were linear and parallel to the standard curve: the correlation coefficient r was 0.99 
and the model was given by the equation y = 1.004x - 0.173. 
Blood samples were collected into tubes containing EDTA at the slaughterhouse. The samples were 
immediately placed in ice, and later centrifuged at 600g for 15 min for separation of plasma. Plasma 
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samples were frozen at -20°C until later analysis. Anti-Mullerian Hormone in plasma was first 
measured with the same kit used for the FF (AMH Gen II ELISA kit) according to the manufacturer’s 
instructions (Beckman Coulter, A73818, USA), as previously described. Unfortunately, the 
sensitivity of this kit was too low to detect any AMH concentration in plasma, so we decided to use a 
new kit, already used in Murrah buffaloes by Baldrighi et al (2014). Therefore, plasma AMH was 
evaluated using an enzyme-linked immunosorbent assay ELISA kit according to the manufacturer’s 
instructions (Ansh Labs, Milan, Italy) as previously described for buffalos (Baldrighi et al., 2014). 
The sensitivity of the AMH assay was 0.011 ng/mL and intra-assay CV was <5%.  
 
RNA Isolation and detection  
Total RNA was purified for each GC sample by using RNeasy Mini Kit (Qiagen, 74104, Germany). 
The protocol was performed according to the manufacturer’s instructions. The final elution step was 
repeated and the purified total RNA was subsequently stored at -80°C. Quantity of the total RNA 
samples was evaluated by Thermo Scientific™ NanoDrop™ 2000 spectrophotometers. The level of 
degradation was analysed using agarose electrophoresis. Samples with Clear 28S and 18S ribosomal 
RNA bands and band intensities of 28S:18S close to two were chosen in this study. 
 
cDNA synthesis  
One μg of detected RNA was used to synthesize first-strand cDNA using the QuantiTect® Reverse 
Transcription Kit (Qiagen, 205311, Germany) according to the manufacturer's protocol. To eliminate 
genomic DNA contamination in RNA samples, the gDNA elimination reaction was performed using 
2 μL of gDNA wipe-out buffer, 1 μg template RNA and RNase-free water to adjust the final volume 
to 14 μL at 42°C for 2 min. Reverse transcription was carried out in a total of 20 μL reaction 
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containing 1 μL Quantiscript Reverse Transcriptase, 4 μL Quantiscript RT buffer with Mg2+ and 
dNTPs, 1 μL RT Primer Mix and 14 μL Template RNA (Entire genomic DNA elimination reaction) 
at 42°C for 15 min and 95°C for 3 min. All steps were performed on ice. The cDNA was stored at -
20°C until real-time PCR analysis.  
 
Real-Time PCR analysis  
Real-time quantitative PCR reactions were run using QuantiFast
® 
SYBR
®
 Green PCR Kit (Qiagen, 
204054, Germany) on BIORAD CFX Manager Machine. The AMHR2, FSHR, LHR, CYP19A1 and 
TP53INP1, CASP3, as well as ACTB primers (shown in Table 1) were designed by Primer Premier 5 
software and synthesized by TSINGKE Biological Technology Company (Wuhan, China). Samples 
were prepared according to the manufacturer’s instructions. A total reaction volume of 20 μL 
contained 10 μL Master Mix, 2 μL primers and 8 μL diluted cDNA (1:30). The samples were then 
centrifuged at 1000 X g at 4°C for 1 min. All cDNA samples were amplified under the following 
conditions: 95°C for 5 min, 40 cycles at 95°C for 10 s and 60°C for 30 s. The data were subsequently 
quantified according to the comparative cycle threshold (CT) method and expression levels were 
presented as 2
-ΔCT
 normalized to the ACTB housekeeping gene.  
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Table 1. Primers used in this study for Real time PCR. 
 
Gene Sequence (5'to3') Accession No. Product size (bp) 
AMHR2 
F attgtccgctttatcaccgc 
XM_006047467.1 213 
R tggtttgtactggccatcct 
CYP19A1 
F gttgcaattcatcggcatgc 
NM_001290963.1 204 
R gtcaacacgtccacatagcc 
FSHR 
F aaacgtgttctccaacctgc 
NM_001290962.1 157 
R cttgtgaacagctggcaagt 
LHR 
F gctctacctgctgctcattg 
XM_006078413.1 216 
R ttcagtcgcagcttttggtc 
TP53INP1 
F 
R 
ataacccaggcagtcccaga 
tggcgacgaaggctatttct 
XM_006076259.1 
181 
CASP-3 
F cagcgtcgtagctgaacgta 
XM_006075118.1 
248 
R ccgcatccacatctgtacca 
ACTB 
F atgatgatattgccgcgctc 
NM_001290932.1 216 
R cgtgctcaatggggtacttg 
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Statistical Analysis 
The differences in AMH concentration in FF and gene expression in GCs among classes of follicles 
were analysed by ANOVA, and Least Significant Difference (LSD) was used as a post-hoc test. 
Pearson correlation analysis was carried out to evaluate the relationship between AMH and the AFC, 
as well as among other reproductive parameters on samples from 54 animals. To evaluate the 
correlation between AMH concentration in FF and gene expression in GCs, samples from 22 animals 
were used. The differences in AMH plasma levels and reproductive parameters, including, between 
good (≥12 follicles) and bad (<12 follicles) donors were analysed by Student’s t test. Differences in 
gene expression levels between good and bad donors were also analysed by Student’s t test. 
Differences in the percentages of grade A+B COCs between good and bad donors were analysed by 
Chi Square test. In all cases a P-value <0.05 was accepted as statistical significance.  
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Results  
 
AMH concentration in FF and gene expression in GCs in relation to follicular size 
Anti-Mullerian hormone concentration in FF decreased (P<0.01) at increasing follicular diameter, as 
shown in Figure 6. Indeed, AMH concentration in small follicles was 4 and 12 times higher than that 
recorded respectively in medium and large follicles. As shown in Figure 7, mRNA expression of 
AMHR2 and FSHR was higher (P<0.05) in small follicles than in medium and large follicles. In 
contrast, mRNA expression of LHR and CYP19A1 was higher (P<0.05) in large follicles than in small 
and medium follicles.  
 
 
Figure 6. Intrafollicular AMH concentration (ng/mL) in relation to the follicular size. 
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Figure 7. Relative mRNA expression of AMHR2, FSHR, CYP19A1 and LHR genes in GCs from total 
106 buffalo antral follicles in relation to follicular diameter. 
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Correlation analysis 
Unexpectedly, no correlations were found between plasmatic AMH levels and all the other 
parameters. In contrast, the AMH concentration in FF of small follicles was positively correlated 
with the AFC (r = 0.31; P<0.05) and with the number of small follicles (r = 0.29; P<0.05). In 
addition, the AFC and the average number of small follicles were positively correlated with the 
number of COCs (r = 0.76; P<0.001 and r = 0.78; P<0.001, respectively) and Grade A+B COCs (r = 
0.52; P<0.001 and r=0.46; P<0.001, respectively). However, no correlation was found between AMH 
concentration and both the number and percentage of Grade A+B COCs.  
The intrafollicular AMH concentration was positively correlated with AMHR2 (r= 0.537; P<0.01) 
and FSHR (r= 0.385; P<0.05) and negatively correlated with CYP19A1 (r=-0.486; P<0.01) and LHR 
(r=-0.499; P<0.01). The AMHR2 was positively correlated with FSHR (r=0.560; P<0.01), while 
CYP19A1 was correlated with LHR (r= 0.535; P<0.01). 
 
Differences between good and bad donors  
No differences were found between good (≥12 follicles; n = 26) and bad (<12 follicles; n = 28) 
donors in the mean weight (5.4 ± 0.2 vs. 5.0 ± 0.3), length (3.3 ±0.1 vs. 3.2 ± 0.1), and width (2.1 ± 
0.1 vs. 2.0 ± 0.1) of the ovaries. Unexpectedly, good and bad donors showed similar AMH plasma 
level (0.155± 0.01 and 0.168 ± 0.01, respectively) but it is worth pointing out that reading was only 
possible at the lower points of the curve and, according to our experience, the assay cannot be 
considered reliable. However, good donors had a higher (P < 0.05) concentration of AMH in small 
follicles than bad donors (Fig. 8).  
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Figure 8. Intrafollicular AMH concentration (ng/mL) in different size follicles in good (≥ 12 
follicles; n =26) and bad (<12 follicles; n =28) buffalo donors. 
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 Bars with different superscript are significantly different; P<0.05 
 
As expected, good donors also had higher numbers of small follicles and COCs (P < 0.01), as well as 
of grade A and B COCs (P < 0.05), as shown in Table 2. However, no differences were found in the 
percentage of superior quality oocytes (grade A and B). 
Interestingly, good donors had higher (P<0.05) AMHR2 levels in small follicles and higher (P<0.05) 
LHR levels in large follicles than bad donors (Figure 9). However, there were no significant 
differences of FSHR and CYP19A1 gene expression between good and bad donors. Likewise, no 
differences were observed in the relative expression of TP53INP1, and CASP3 in GCs between good 
and bad donors (Figure 10). 
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Table 2. Differences between good (≥ 12 follicles; n=26) and bad (< 12 follicles; n=28) donors in the number of total (TFL), small (SFL), 
medium (MFL) and large (LFL) follicles, COCs, good quality COCs (G. A+B), recovery rate and the percentage of good quality COCs. Data are 
presented as mean ± SE. 
 
Donors 
SFL 
n. 
MFL 
n. 
LFL 
n. 
TFL 
n. 
COC 
n. 
Recovery rate 
% 
G. A+B 
n. 
G. A+B 
% 
Bad 7.9 ± 0.3
A
 0.8 ± 0.2 0.8 ± 0.1 8.9 ± 0.4
A
 5.5 ± 0.6
A
 62.5 ± 7.2 1.9 ± 0.3
a
 36.3 ± 5.7 
Good 14.8 ± 0.9
B
 1.4 ± 0.4 0.6 ± 0.1 16.2 ± 0.8
B
 11.4 ± 1.2
B
 68.1  ± 4.9 3.4 ± 0.6
b
 31.9  ±  5.0 
Total 11.2 ± 0.7 1.1 ± 0.2 0.7 ± 0.1 12.4 ± 0.7 8.3 ± 0.8 65.2 ± 4.4 2.6 ± 0.4 34.1 ± 3.8 
A, B
 Values with different superscripts are significantly different; P<0.01 
a, b
 Values with different superscripts are significantly different; P<0.05 
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Figure 9. Relative mRNA expression of AMHR2, CYP19A1, FSHR and LHR in good (≥ 12 
follicles; n=12) vs bad (< 12 follicles; n =10) donors.  
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Figure 10. Relative mRNA expression of TP53INP1 and CASP3 in GCs of small follicles 
from good (≥ 12 follicles; n=12) and bad (< 12 follicles; n =10) donors.  
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Discussion 
 
To our knowledge, this is the first study to integrate information of intrafollicular 
concentration of AMH in different size follicles with the expression of four genes, known to 
be involved in folliculogenesis and steroidogenesis, namely AMHR2, FSHR, LHR and 
CYP19A1 by corresponding GCs in buffalo. Knowledge of factors involved in regulating 
follicular growth may be useful to gain insights into the causes of failure in response to 
hormonal stimulation in this species. Furthermore, as the ovarian follicular reservoir in 
buffalo is low, strongly limiting the application of reproductive technologies, and high 
individual variability in follicular recruitment is recorded (Gasparrini et al., 2014), 
64 
 
identification of a reliable marker predictive of the population of the small antral 
gonadotrophin-responsive follicles is fundamental. Therefore, another goal of the work was 
to assess whether plasmatic and intrafollicular AMH concentrations were correlated to the 
AFC and to evaluate differences in reproductive parameters between good and bad donors.  
The results of this study demonstrated that intrafollicular AMH concentration decreases at 
increasing follicular size, with the small follicles (3-5 mm) contributing most of the AMH, 
similar to other species (Eilsø Nielsen et al., 2010; Monniaux et al., 2011; Rico et al., 2011). 
The total AMH content per follicle significantly decreased in medium follicles (5-8 mm) and 
was further reduced in large follicles (> 8 mm). The small follicles, in addition to the highest 
intrafollicular AMH concentration, also showed the highest expression of AMHR2, which 
encodes the specific AMH type II receptor, suggesting an autocrine mechanism in regulating 
follicular development. Interestingly, the highest expression in GCs of FSHR was also 
observed in small follicles, while it decreased 2-fold in both medium and large follicles. A 
decrease in FSHR expression in GCs was also previously reported in large compared to small 
follicles in other species (Monniaux et al., 2011; Catteau-Jonard et al., 2008). The positive 
correlation between the intrafollicular AMH concentration and the expression of AMHR2 and 
FSHR in GCs confirms these findings and suggests that these may be functional markers of 
immature GCs. As expected, both the expression of LHR and CYP19A1, markers of 
maturation and differentiation of GCs (Rico et al., 2009), increased in follicles > 8 mm, 
indicating that they had reached the maturity stage of preovulatory follicles. It is indeed 
known that the expression of CYP19A1 gene, encoding the aromatase, increases in GCs since 
the stage of follicular selection, leading to enhanced oestradiol secretion. Moreover, the GCs 
become more responsive to LH, through an increased expression of LHR gene, encoding the 
LH receptor, in the preovulatory follicle (Clément and Monniaux, 2013).  
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The negative association between AMH concentration and the expression of CYP19A1 in the 
corresponding GCs, observed in this work confirms previous reports (Rico et al., 2009; 
Jeppesen et al., 2013) and suggests a role of AMH within small follicles to prevent premature 
oestrogen production. In the present study, a negative correlation was also found between 
AMH concentration and the expression of LHR by GCs. This is in line with an earlier in vitro 
study that demonstrated an inhibitory effect of AMH on the induction of CYP19A1 and LH 
receptors by FSH in rat and porcine GCs (Di Clemente et al., 1994). 
Another interesting finding arising from the study was the positive correlation found between 
the intrafollicular AMH concentration and both the AFC and the number of small follicles, 
suggesting that AMH can be used as a marker of the population of gonadotrophin-responsive 
follicles in buffalo. The importance of this finding is highlighted by the high correlation 
between the AFC and both the number of COCs and Grade A+B COCs. However, in contrast 
to previous works in other species (Rico et al., 2009; Monniaux et al., 2011), including 
Murrah buffalo (Baldrighi et al., 2014), the AMH levels in plasma were not correlated to the 
AFC. It is worth to point out that two different kits were used in the present study, including 
the kit previously employed to measure the plasmatic AMH level in Murrah buffaloes 
(Baldrighi et al 2014). The first kit (AMH Gen II ELISA kit, Beckman Coulter, A73818, 
USA), reliable to detect AMH in FF, did not allow to measure AMH in plasma. For this 
reason, we repeated the analysis with the kit (Ansh Labs, Milan, Italy) used by Baldrighi et al 
(2014). This allowed to measure AMH but, as reading was only possible at the lower points 
of the curve, according to our experience the assay was not reliable. It is worth mentioning 
that the other authors also encountered the same problem in measuring plasmatic AMH levels 
in buffalo. It is known that AMH concentration is much lower in plasma than in FF in other 
species (Monniaux et al., 2012) but these results suggest that in buffalo the AMH 
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concentration in plasma is even lower and that, in order to use this as a marker to screen 
donors, a more reliable specific assay should be developed.   
The importance of selecting buffalo cows to enrol in embryo production programs suggested 
comparing the most relevant reproductive parameters between good (≥ 12 follicles) and bad 
(< 12 follicles) donors. Despite the larger AFC, the ovaries of good donors had similar weight 
and size to those of bad donors. Nevertheless, they showed larger numbers of small follicles, 
COCs and Grade A+B COCs compared to bad donors, confirming previous findings 
(Gasparrini et al., 2014). However, the increased number of Grade A+B COCs depends on 
the greater AFC, as no effect was observed on the percentage of superior quality oocytes, 
evaluated by morphological criteria. As previously discussed, the failure in highlighting 
differences in plasmatic AMH levels between good and bad donors may be due to the 
sensitivity of the kit. Interestingly, good donors had both higher levels of AMH in the FF and 
higher expression of AMHR2 in corresponding GCs in small follicles, as well as higher 
expression of LHR in large follicles. The latter finding indicates that good donors, in addition 
to the expected higher AFC, also differ from bad donors in improved maturation of large 
follicles and hence in oocyte competence, suggesting a better response to embryo production 
technologies. It has been reported elsewhere that AMH expression is higher in healthy 
follicles than atretic follicles, speculating that AMH inhibits apoptosis in granulosa cells 
(Rico et al., 2009; Lehmann et al., 2014). The higher AMH concentrations in FF and the 
expression of AMHR2 in corresponding GCs found in this study in good donors suggest that 
these may have a lower atresia rate. To evaluate the phenomenon, we have chosen an 
upstream regulator of apoptosis, i.e. TP53INP1, a good molecular candidate of atresia, 
according to Hatzirodos et al (2014) and CASP3, known to be a downstream executioner 
caspase responsible for degradation of cellular proteins (Creagh et al., 2001; Riedl and Shi, 
2004). As no significant change in the expression of both apoptosis-related genes was 
67 
 
detected in small follicles between good and bad donors, this hypothesis appears to be ruled 
out.  
In conclusion, it was demonstrated that the intrafollicular AMH concentration shows an 
inverse pattern to follicular size in buffalo. Moreover, small follicles have a higher expression 
of AMHR2 and FSHR and a lower expression of LHR and CYP19A1 in corresponding GCs 
compared to medium and large follicles. Good donors showed higher levels of AMH and 
greater mRNA expression of AMHR2 in small follicles and higher expression of LHR in large 
follicles. The positive correlation found between intrafollicular AMH concentration and the 
AFC suggests that AMH is indeed a marker of follicular reserve also in buffalo. However, no 
correlation was observed with the plasmatic AMH levels, likely because of the poor 
sensitivity of the available kits. The use of intrafollicular AMH concentration would imply 
the collection of FF by transvaginal aspiration prior enrolment of donors, which is certainly 
less practical than the AFC itself. Therefore, at present the only reliable practical way to 
select donors to for embryo production programs is to evaluate the AFC.  
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EXPERIMENT 2  
 
Utilization of eCG during the final stages of follicular growth in a 
superovulation protocol 
 
It is well known that FSH plays a pivotal role during the early stages of follicular 
development, ensuring follicular recruitment and growth (Adams et al 1992, 1993) until the 
dominant follicle reaches a certain size, i.e. 8.5 mm diameter in Bos Taurus (Ginther et al 
1996) 6.2 mm in Bos indicus (Sartorelli et al 2005, Gimenes et al 2008) and 7.2 mm in 
buffalo (Gimenes et al 2011). At this stage, after acquisition of LH receptors, the dominant 
follicles switch to LH-dependence (Mihm and Evans 2008). It follows that, in order to better 
mimic the follicular dynamics in superovulated animals, FSH should be given first to ensure 
follicular growth, followed by LH administration at the time of presumptive follicular 
deviation. Equine chorionic gonadotrophin, characterized by both FHS and LH activity, can 
be used for this purpose. Recent studies (Barros et al., 2008; Sartori et al., 2009; Mattos et al., 
2011) have evaluated the possibility of replacing the last injections of FSH with eCG during 
the superovulatory treatment in Bos Indicus with opposing results. In fact, some authors 
(Barros et al., 2008) have observed a better response to superovulation in animals treated with 
eCG, while others (Sartori et al., 2009) have not described any favourable effect. In both 
cases, the last two injections of FSH were replaced with 2 injections of 150 IU eCG. In 
Italian Mediterranean buffalo eCG has been used in progestin-based synchronization 
protocols at a dose of 1000 IU (Neglia et al., 2003). It was recently observed that a single 
administration of 500 IU of eCG on Day 7 of an Ovsynch synchronization protocol does not 
increase follicular growth until the day of fixed time insemination (Neglia et al., unpublished 
results). To our knowledge, however, the inclusion of eCG near the end of the superovulation 
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protocol has still not been evaluated in buffalo. Therefore, the aim of the present experiment 
was to assess the efficacy of replacing the last four FSH injections with a single 
administration of 1000 IU of eCG compared to the conventional FSH decreasing 
superovulation protocol in Italian Mediterranean Buffalo. In particular, the comparison of the 
two superovulation protocols was based on the study of follicular dynamics and the 
evaluation of CL and embryo yields. 
 
Materials and Methods 
The Ethical Animal Care and Use Committee of the University of Naples Federico II 
(Naples, Italy) approved the experimental design and animal treatments.  
 
Animals and housing 
The study was carried out on multiparous Italian Mediterranean buffaloes (n = 20) located at 
two commercial buffalo dairy farms in the South of Italy (between 40.5° N and 41.5° N 
parallel). The study coincided with the transition to seasonal anoestrus (from January to May) 
when many buffaloes become non-cyclic as a result of increasing day-length. Buffaloes were 
milked twice daily and were at 95±38 days post-partum at the beginning of the study. 
Animals were maintained in open yards on a cement pad that allowed 15 m
2
 per animal and 
fed with a total mixed ration that consisted of 50-55% forage and 50-45% concentrate, 
containing 0,90 UFL/Kg of dry matter (DM) and 15% crude protein/DM. 
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Synchronization and MOET scheme 
Animals were synchronized with a double injection of 0.524 mg of a PGF2α analogue 
(Cloprostenol, Estrumate® Schering-Plough Animal Health, Milan, Italy) spaced 12 days 
apart, to induce luteolysis and synchronize the occurrence of oestrus. Because of the low 
intensity of oestrous behaviour of buffalo (Ohashi 1994), 60 h after the last injection of 
PGF2α, animals were subjected to trans-rectal examination of the genital tract by ultrasound 
(Aloka SSD-500, Tokyo-Japan) to assess oestrus status (follicle >1.2 cm and a tonic uterus 
with the presence or absence of mucous vaginal discharge). Only buffaloes that responded to 
synchronization underwent the superovulation treatment, while the remaining animals were 
excluded from the trial. Therefore, on the day of ultrasonographic study (day of oestrus or 
day 0), an intravaginal progesterone implant (CIDR®, Zoetis, Rome, Italy) was inserted only 
in the animals selected for the trial on the basis of the response to synchronization. 
Superovulation treatment started 8 days after oestrus detection and insertion of the CIDR®. 
In particular, animals were divided into two groups (A and B) homogeneous for days open, 
number of lactations and average production recorded in the last 7 days: 
a) The Group A (n = 6) received a double daily dose of 400 mg of FSH (Folltropin ®, Bio98, 
Milan, Italy) in a dose dependent manner for four consecutive days. Briefly, the scheme was 
80 mg on day 8, 60 mg on day 9, 40 mg on day 10, and 20 mg on day 11, given twice daily. 
At day 10 (72 and 84 hours after the start of treatment with gonadotropins) all treated 
buffaloes were subjected to a double injection of 0.524 mg PGF2α (Cloprostenol, 
Estrumate®, Schering-Plough Animal Health, Milan, Italy) to induce luteolysis. 
b) The buffaloes of Group B (n = 7) received a superovulation treatment lasting four days. In 
particular, the treatment was the same as in Group A for the first two days, while the last four 
injections of FSH were substituted with a single injection of 1000 IU of pregnant mare serum 
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gonadotropin (eCG; Ciclogonina, Zoetis, Rome, Italy). At day 10 (72 and 84 hours after 
initiation of treatment with gonadotropins) all treated buffaloes were subjected to a double 
injection of 0.524 mg PGF2α (Cloprostenol, Estrumate®, Schering-Plough Animal Health, 
Milan, Italy) to induce the luteolysis. 
All cows were artificially inseminated at oestrus with single straw semen from bulls of 
proven fertility.  
 
Ultrasound examination 
Ultrasonographic investigations in the two groups were carried out at the time of CIDR 
insertion to verify the response to synchronization treatment. Furthermore, the follicular 
dynamics in the two groups was assessed daily, from the beginning to the end of treatment. 
Further ultrasound examinations were carried out 48 hours after oestrus, to check the 
ovulation rate. Ovulations occurring 48 hours after oestrus were not considered. In every 
ultrasound examination the total number and the size of follicles were recorded. In particular, 
follicles were classified into three categories depending on the diameter: 
• Small: with a diameter between 0.20 and 0.50 cm; 
• Medium: with a diameter between 0.51 and 1.00 cm; 
• Large: with a diameter greater than 1.00 cm. 
 
Assessment of CL and embryo yields 
Six days after oestrus ultrasound examination was carried out to establish the number and 
size of corpora lutea on the ovaries. Then ova and embryos were collected by a nonsurgical 
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procedure (Newcomb et al., 1978), evaluated and classified as quality I embryos (freezable), 
quality II embryos (transferable) and degenerated embryos based on the IETS guidelines 
(Stringfellow and Seidel, 2007). 
 
Statistical Analysis  
All statistical analyses were performed using SPSS Software (SPSS 2005). In particular, data 
regarding the incidence of the different follicular categories were analysed by chi-square test. 
The average number of total follicles and that of all follicular categories were compared 
between groups using the Student’s t test. Differences in the average follicular diameter for 
each category of follicles during the superovulatory treatment until oestrus were also 
compared using Student's t test. Differences were considered statistically significant when 
they reached at least the 5% confidence level. Differences of less than 10 % were considered 
to be indicative of a trend. 
 
Results 
 
The response to synchronization was 65 % (13/20), in agreement with previous studies 
(Neglia et al., 2010). Both the number of total follicles and the number of follicles of 
different categories, recorded at the beginning of the superovulatory treatment (day 8), and 
after the first four injections of FSH (day 10) were similar in Group A and Group B (Table 
3). At the time of oestrus (Day 13), animals treated with eCG (Group B), despite a similar 
number of total follicles, had a higher incidence (P = 0.06) of large follicles compared to 
Group A (Table 3). 
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Table 3 -  Average number of small (SFL), medium (MFL), large (LFL) and total (TOT FL) follicles recorded in in buffaloes superovulated 
with FSH (Group A) and a FSH + eCG (Group B), at the beginning of superovulatory treatment (day 8), at the beginning of eCG treatment in 
group B (day 10) and at oestrus (day 13). 
 
a,b
 Values with different superscripts are significantly different; P=0.06. 
  
Group SFL MFL LFL TOT FL 
Day Day Day Day 
 8 10 13 8 10 13 8 10 13 8 10 13 
    A  
(n=6)  
7.8±1.5 
(47) 
4.7±1.1 
(28) 
3.2±0.7 
(19) 
1.5±0.3 
(9) 
8.5±0.7 
(51) 
5.5±1.4 
(33) 
1.0±0.0 
(6) 
1.2±0.2 
(7) 
3.3±0. 7
a
 
(20) 
10.3±1.5 
(62) 
14.3±1.2 
(86) 
12.0±1.5 
(72) 
   B  
(n=7)  
7.7±1.8 
(54) 
4.7±1 
(33) 
2.6±1.2 
(18) 
1.6±0.6 
(11) 
8.3±1.2 
(58) 
5.0±1.1 
(35) 
1.0±0.0 
(7) 
1.0±0.0 
(7) 
5.6±1.6
b
 
(39) 
10.3±2.1 
(72) 
14.0±1.6 
(98) 
13.1±2.0 
(92) 
74 
 
Although the number of dehiscent follicles within 40 hours after oestrous was not different 
between the two treatments (2.83±0.60 vs. 4.43±0.78, Group A and Group B, respectively), 
the animals of Group B showed a higher number of ovulations within the first 28 hours 
(0.50±0.22 vs. 3.14±0.74; P<0.01 in Groups A and B, respectively). The mean follicular 
diameter within follicular categories (Table 4) was similar in the two groups at the beginning 
of the superovulatory treatment (day 8) and after the first four injections of FSH (day 10). 
The mean diameter of the small and medium follicles was also not affected by treatment at 
the time of oestrus (Table 4). On the contrary, the average diameter of large follicles, 
recorded at the day of oestrus was greater (P <0.05) in Group B compared to Group A 
(1.34±0.07 vs. 1.54±0.06, Group A and Group B, respectively). 
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Table 4 - Average diameter (cm) of small (SFL), medium (MLF) and large (LFL) follicles, recorded in buffaloes superovulated with FSH 
(Group A) and a FSH + eCG (Group B) at the beginning of superovulatory treatment (day 8), at the beginning of eCG treatment in group B (day 
10) and at oestrus (day 13). 
 
 
 
 
 
 
a,b
 Values with different superscripts within columns are significantly different; P<0.05. 
 
Group 
SFL MLF LFL 
Day Day Day 
8 10 13 8 10 13 8 10 13 
A 
(n=6) 
0.3±0.0 
(47) 
0.4±0.0 
(28) 
0.3±0.0 
(19) 
0.6±0.0 
(9) 
0.7±0.0 
(51) 
0.7±0.0 
(33) 
1.4±0.1 
(6) 
1.5±0.1 
(7) 
1.3±0.1
a
 
(20) 
 B 
(n=7) 
0.3±0.0 
(54) 
0.4±0.0 
(33) 
0.3±0.0 
(18) 
0.6±0.0 
(11) 
0.7±0.0 
(58) 
0.7±0.0 
(35) 
1.4±0.1 
(7) 
1.5±0.1 
(7) 
1.5±0.1
b
 
(39) 
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Furthermore, six days after oestrus, at the time of flushing, ultrasound examination of 
the ovaries highlighted a higher number (P = 0.07) of large follicles (anovulatory 
follicles) in Group B compared to Group A (Table 3). Moreover, the average diameter 
of medium and large follicles was higher (P<0.01) in buffaloes of the Group B 
compared to Group A (Table 5). 
 
Table 5. Average number and diameter of small (SFL), medium (MFL), large (LFL) 
and total (TFL) follicles, recorded in buffaloes superovulated with FSH (Group A) 
and a FSH + eCG (Group B) at the time of flushing (6 days after oestrus). 
 
 
A, B
 Values within columns with different superscripts are significantly different; P<0.01 
a, b
 Values within columns with different superscripts are different; P = 0.07 
 
No differences were recorded in the number and area of CL, in the number of 
embryos recovered and in the recovery rate between groups; however, a higher 
(P=0.06) number of ova was collected in group A (Table 6). 
 
Group n. SFL 
 
Diameter 
(cm) 
 SFL 
n. MFL 
 
Diameter 
(cm)  
MFL 
n. LFL 
 
Diameter 
(cm) 
LFL 
n. TOT 
FL 
 
Diameter 
(cm) 
TFL 
 A 
(n=6) 
2.3 ± 0.9 
 
0.3 ± 0.0 1.3 ± 0.6 
 
0.7 ± 0.0
A
 1.7 ± 0.5
a
 
 
1.4 ± 0.1
A
 5.3 ± 0.7 
 
0.8 ± 0.1
A
 
 B 
(n=7) 
1.4 ± 0.5 
 
0.3 ± 0.0 2.3 ± 0.6 
 
0.8 ± 0.0
B
 4.3 ± 1.1
b
 
 
1.9 ± 0.1
B
 8.0 ± 1.3 
 
1.3 ± 0.1
B
 
Total  3.7 ± 0.7 0.3 ± 0.0 3.6 ±0.6 0.8 ± 0.0 6.0 ± 0.9 1.7 ± 0.1 13.3 ± 1.0 1.0 ± 0.1 
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Table 6. Number and area of corpora lutea (CL), embryos and ova recovered and 
recovery rate (RR) on day 6 after oestrus in buffaloes superovulated with FSH (Group 
A) and a FSH + eCG (Group B). 
 
 n. CL CL area (cm
2
) n. Embryos n. Ova RR (%) 
Group mean ± SE mean ± SE mean ± SE mean ± SE mean ± SE 
A (n =6) 6.3 ± 2.4 1.3 ± 0.2 1.3 ± 1.3 2.0 ± 1.2
a
 31.4 ± 24.6 
B (n =7) 4.4 ± 0.7 1.5 ± 0.3 0.6 ± 0.4 0.8 ± 0.6
b
 12.6 ± 8.5 
Total 5.35 ± 1.5 1.4 ± 0.3 0.9 ± 0.5 1.3 ± 0.6 19.6 ± 10.1 
 
a,b
 Values within columns with different superscripts are different; P =0.06 
 
Discussion 
 
The results of this experiment demonstrated that the strategy to replace the last FSH 
doses with a single administration of eCG (group B) was effective in increasing the 
response to superovulation, as indicated by the increased number and greater diameter 
of large follicles at oestrus and by the higher incidence of ovulations occurring within 
28 h post-oestrus. Nevertheless, the number of ovulations within 40 h post-oestrus, as 
well as the number and area of CL found on day 6 post-oestrus were similar in the two 
groups. In addition, a higher number of large follicles was observed on day 6 post 
oestrus in group B. Finally, although the number of viable embryos recovered was 
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similar, the average number of ova was higher (P= 0.06) in group A, i.e. conventional 
FSH treatment. 
The main objective of the superovulatory treatment is to obtain a high number of 
embryos from high genetic merit subjects (Mapletoft et al., 2002; Mapletoft & Bo, 
2012). Although this technique is routinely used in cattle, with an average recovery of 
5 good quality embryos (Galli and Lazzari, 2005), in buffaloes, despite the numerous 
studies carried out over the past 20 years by researchers around the world, the average 
recovery is around two embryos per animal (Misra, 1993; Zicarelli et al., 1997b; 
Carvalho et al., 2002; Neglia, 2006; Misra & Tyagi, 2007; Neglia et al., 2010). One of 
the limitations of MOET in buffalo species is the selection of cyclical subjects that are 
more likely to be responsive (producing at least one embryo) to the superovulatory 
treatment (Zicarelli, 1997b; Neglia et al., 2010). In our study, we synchronized the 
buffaloes with a double injection of an analogue of PGF2α. This allowed us to select 
cyclical subjects and then discard those in anoestrus, which could misrepresent the 
results of follicular dynamics. In this study, buffaloes that received eCG in the last 
two days of the superovulatory treatment presented a greater number of large follicles 
at the time of oestrus, and thus a better response to superovulation, compared to those 
who received four FSH injections. The hormonal treatments mainly used in 
superovulation programs are based on gonadotrophins (FSH and LH) and on equine 
chorionic gonadotropin. The need to administer FSH and LH at different times during 
superovulatory treatment has been a much debated topic. Basic studies on follicular 
development showed that the follicular growth, when follicles have a diameter of at 
least 0.4 cm, is closely FSH-dependent (Lucy, 2007), since FSH allows follicular 
recruitment (Adams et al., 1992; Adams et al., 1993). This is true until the dominant 
follicle reaches 0.85 cm in diameter in Bos Taurus (Ginther et al. 1996) and 0.62 cm 
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in Bos Indicus (Sartorelli et al. 2005; Gimenes et al. 2008). Recent studies carried out 
in Murrah buffalo heifers (Gimenes et al., 2011) have shown that the deviation of the 
dominant follicle takes place when the latter reaches the diameter of 0.72 cm. In 
contrast, a positive response to GnRH in terms of ovulation rates was observed in 
follicles of about 0.5 cm in diameter in the Italian Mediterranean buffalo (Campanile 
et al., 2008). In any case, after the selection and deviation phase, the dominant 
follicles acquire LH receptors on the granulosa and theca cells and become LH-
dependent (Lucy, 2007; Mihm & Evans, 2008). Studies carried out in the 90s (Xu et 
al., 1995) using in situ hybridization technique demonstrated that, at least in bovine, 
FSH receptors continue to be expressed on the granulosa cells throughout follicular 
development, while disappear in swine upon the transition of the follicle from FSH to 
LH dependent-phase (Liu et al., 2004). It is clear, therefore, that the follicles of 
superovulated animals could benefit from the LH administration, especially at the end 
of the superovulation protocol. Equine chorionic gonadotrophin is a complex 
glycoprotein, characterized by a long half-life (over 40 hours), which has both LH and 
FSH-like action (Steward et al. 1976; Licht et al. 1979; Murphy & Martinuk 1991) 
and could be a constant stimulus to the LH receptors of growing follicles towards the 
end of a conventional FSH-based superovulation treatment.  
After the first two days of FSH treatment, over 60% of medium follicles with a 
diameter greater than 0.65 cm were recorded both in Groups A and B. It is likely, 
therefore, that these follicles passed the stage of deviation and acquired the LH 
receptors. The substitution of the last four doses of FSH, which represent the 30% of 
the total of the superovulatory treatment, with a single dose of eCG has allowed the 
growth of a greater number of follicles, as also demonstrated by the fact that the 
diameter of large follicles in Group B was greater compared to Group A. These results 
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would be, at least in part, in agreement with a recent study in the Bos Indicus in which 
the last two FSH administration were replaced by two injections of 150 IU of eCG 
and the animals treated with eCG showed a greater number of large follicles than 
those that received FSH injections (Mattos et al., 2011). However, the last two doses 
of FSH were replaced by only two injections of 300 IU eCG in total, while in our 
study we used a single dose of 1000 IU eCG. Moreover, during the oestrous cycle Bos 
Indicus has a number of follicles considerably greater than Bos Taurus (Sartori and 
Barros, 2011) and buffalo (Baruselli et al., 1997; Neglia et al., 2007) and hence the 
administration of only 300 IU could be sufficient to ensure adequate follicular growth 
in this species in the last days of the superovulatory treatment. In this experiment, due 
to the low population of primordial follicles in buffalo (Danell, 1987) it was thought 
to support the follicular growth with a greater amount of eCG. It is worth pointing out 
that the greatest diameter, reached by large follicles in Group B, also resulted in a 
higher rate of ovulation within 28 hours. The phenomenon of ovulation involves a 
complex series of biochemical and biophysical events that leads to dehiscence of the 
preovulatory follicle (Lucy, 2007; Sirois et al., 2004). It is known that the induction of 
ovulation via exogenous administration of GnRH or hCG of follicles with a diameter 
less than 1.15 cm could determine the formation of smaller corpora lutea that produce 
lower amounts of progesterone than dominant follicles showing a greater size 
(Vasconcelos et al., 2001). Furthermore, the diameter of the dominant follicle is 
closely related to the oestradiol blood concentration (Perry et al., 2006), which is able 
to act by positive feed-back at the hypothalamic level on the LH release. The action of 
LH causes the activation of the cyclooxygenase-2 (COX-2) in the ovary (Sirois et al., 
2004) and, consequently, the synthesis of prostaglandins that promote ovulation. It is 
conceivable, therefore, that the presence of a larger size dominant follicles in the 
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group of buffaloes treated with FSH / eCG has favoured the release of increased 
amounts of oestradiol and hence, LH, leading to anticipation of the activation of 
COX-2 and then ovulation. In Group A, on the contrary, the highest rate of ovulation 
occurred within 40 h. In any case, the administration of eCG was not able to avoid the 
problem of anovulatory follicles. The long half-life of eCG is an advantage in some 
cases, since it allows to implement the treatment of superovulation by performing a 
single administration, on the other hand is a disadvantage, since even after oestrous, 
the hormone continues to exert its action, causing a further growth of the non-
ovulated follicles (Mapletoft and Bo, 2012). A high number of large follicles at the 
time of uterine flushing translates into both a lower number of embryos recovered and 
worse embryo quality (Gonzalez et al. 1994): the complexity in the embryo collection 
is mainly due to the presence of mucus in the cervix and in the uterus which obstructs 
the catheter during flushing. The worst quality of the embryos could be due to the 
oestrogen action, secreted by dominant follicles, that create an unsuitable oviductal 
and uterine environment. In our study anovulatory follicles were more in number and 
in size in Group B rather than in Group A, and this is perfectly in line with those 
reported in literature. In addition, the higher number of large follicles at oestrus and 
the higher ovulations recorded within 28 h did not result in an increased number of 
CL recorded at day 6 after oestrus, as well as the number of embryos recovered. In 
contrast, a higher number of ova was collected from buffaloes that underwent the 
conventional FSH protocol.  
In conclusion, the replacement of the last four injections of FSH with a single 
administration of eCG within a superovulation protocol in buffalo allows a good 
superovulatory response, both in terms of number and size of follicles and in terms of 
ovulation, without improving the embryo recovery rate. The presence of a very high 
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number of large follicles six days after oestrus in the treated animals may account for 
the decreased ova recovery. This is likely due to the long half-life of eCG and hence 
an efficient alternative could be the use of anti-eCG antibody, in order to block the 
action of the hormone still circulating but further studies are needed to assess this 
hypothesis. However, what is overwhelming is the very poor recovery rate, i.e. the 
ova recovered in relation to the number of CL, recorded in both groups (on average < 
20%). This suggests that, in order to improve the MOET efficiency in buffalo, more 
efforts should be made to better comprehend the mechanism and factors involved in 
the failure of ovum capture by the oviduct. 
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EXPERIMENTS 3 and 4 
 
Analysis of factors involved in the failure of ovum capture in 
superovulated buffaloes 
 
The poor number of embryos recovered per donor is undoubtedly the major constrain 
of MOET in buffalo. Several hypotheses have been formulated over the years to 
explain the low embryo recovery recorded in this species after MOET treatment. 
Several studies (Baruselli et al., 1999; Carvalho et al., 2002; Neglia et al., 2010) 
demonstrated that, despite a very low embryo/ova recovery rate (13-35%), 
superovulation results in the growth of a high number of ovulatory follicles, together 
with a relatively high ovulation rate (50-70%). Therefore, a limited capacity for 
follicular growth and ovulation, arising from the reduced number of primordial 
follicles typical of the species (Danell, 1987), cannot account for the poor embryo 
outcome recorded in superstimulated buffaloes. In superovulated buffaloes sacrificed 
at different days after AI the ratio of ova recovered in relation to the CLs after 
flushing of both oviducts and uteri was still low (Carvalho et al., 2006). As a 
consequence, the most likely hypothesis is that in superovulated buffaloes a failure in 
the ovum capture by the oviduct fimbria occurs. According to Hunter et al. (1988), the 
two main mechanisms involved in female gametes transport are the cilia beating of 
the oviduct epithelium and the smooth muscles contraction waves of myosalpinge. It 
has been shown that one of the factors involved into the regulation of oviductal 
contraction-relaxation and gamete/embryo transport is the active oviductal VEGF 
system during the peri-ovulatory period (Wijayagunawardane et al., 2005). Carvalho 
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(2006) found that buffalo’s ovary adheres more firmly to the mesovarium than the 
cow’s ovary. This feature, in association with hormonal changes observed during the 
superovulatory treatments (e.g. high oestradiol concentrations), could compromise the 
ovum capture and transport trough the oviduct. Indeed, since buffaloes have lower 
plasmatic levels of oestradiol (E2) than cows during the normal oestrous cycle (Batra 
and Pandey 1983) it is possible that they are more sensitive than cattle to the increase 
of plasmatic levels of 17β-oestradiol during the superovulatory treatments (Beg et al., 
1997). Working with superovulated buffalos, Misra et al. (1998) speculated that high 
E2 level for long time, or a high E2/P4 ratio could increase the turgidity of the genital 
system and make more difficult the ovum capture by the oviduct fimbria. In fact, the 
imbalance between the levels of steroid hormones or the increased E2/P4 ratio may 
impair the interaction between the ovum and the ciliates cells of endosalpinge during 
the ovulations. Moreover, high concentrations of E2 found in superovulated small 
ruminants promote a reversal peristalsis of the oviduct, which may cause loss of ovum 
from the oviduct to the abdominal cavity (Bellve and McDonald 1970). Baruselli et al. 
(2002) speculated that a reduction of E2 plasmatic levels would decrease the turgidity 
of the oviduct providing greater mobility of the fimbria. However, exogenous P4 
given between the administration of prostaglandin F2 alpha (PGF2α) and LH in 
superovulated buffaloes reduced E2 blood concentrations, without improving the 
embryo recovery rate.  
Another critical point could be the binding of the newly ovulated COC to the ciliary 
tips of the epithelial cells lining the distal region of the oviduct. The degree of 
adhesion controls the pick-up and subsequent transport and compaction of the 
complex that allows its passage into the oviduct lumen, where it will contact the 
sperm that are swimming up the oviduct. Interestingly, a lower adhesion of cumulus 
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cells to the oocyte, as well as a reduced expansion of cumulus after maturation are 
observed in buffalo (Gasparrini, 2002). A reduced extracellular matrix resulting from 
inappropriate cumulus expansion may lead to a lower cohesion between the oviduct 
cilia and COCs and to a higher difficulty for COCs to move into the infundibulum.  
A better comprehension of the mechanism and factors involved in the failure of ovum 
capture and transport is critical to develop corrective strategies in order to improve the 
efficiency of MOET in buffaloes. Therefore, the aim of our study was to evaluate at 
different levels the various factors involved in this phenomenon. Due to both the 
difficulty of heat detection in this species (Ohashi, 1994; Roy et Prakash, 2009) and to 
the high efficiency of synchronization (Neglia et al., 2003; Rossi et al., 2014; 
Campanile et al., 2016) we decided to use animals synchronized by Ovsynch as a 
control group. However, it is known that the response to Ovsynch program varies 
according to the presence of a dominant follicle and hence to the occurrence of 
ovulation after the first GnRH injection (around 60% Vasconcelos et al., 1999; Bello 
et al., 2006; Carvalho et al., 2015). This aspect has still not been truly investigated in 
buffalo. Therefore, in order to select the most reliable control group for the 
superovulation study, we carried out a preliminary experiment (Experiment 3) aimed 
to assess the relationship between the ovarian follicular response at the start of an 
Ovsynch program and the pregnancy outcome. The results of this experiment allowed 
us to better plan the experiment 4, by selecting the animals that ovulated after the 1
st
 
GnRH as a control group to compare with superovulated animals.  
The aim of Experiment 4 was to compare the morphological parameters of the 
follicles and the steroid profile (progesterone and oestradiol) both in plasma and 
follicular fluid in the peri-ovulatory period in superovulated vs synchronized 
buffaloes. Furthermore, to investigate whether the failure is linked to lack of capture, 
86 
 
the oocyte morphology and expansion, as well as the mRNA expression of factors 
involved in cumulus expansion (FSHr and LHr) in granulosa cells were evaluated. In 
addition, the mRNA expression of substances playing a role on contraction-relaxation 
of the oviduct like ER1, PGR, VEGF and its receptors FLK1 and FLT1 was analysed. 
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Experiment 3 
 
Relationship between the ovarian follicular response at the start of an 
Ovsynch-TAI program and pregnancy outcome in the 
Mediterranean river buffalo 
 
Materials and Method  
 
The Ethical Animal Care and Use Committee of the Federico II University of Naples 
approved the experimental design and animal treatments. 
 
Location and animals  
The study was carried out on a commercial buffalo dairy located in southern Italy 
between 40.5°N and 41.5°N. Italian Mediterranean river buffaloes were maintained 
on cement pads that allowed 15 m
2
 for each animal and 80 cm manger space. The 
buffaloes were milked twice daily and were fed a total mixed ration based on corn 
silage, wheat straw, soybean meal, barley meal, corn meal, wheat bran, beet pulp, 
hydrogenate vegetable fat, and vitamin and mineral supplement. A total of 116 
pluriparous buffaloes (118 ± 65 days in milk) were chosen for the study after two 
clinical examinations 12 days apart (palpation of the ovaries for a follicle > 1.0 cm 
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and/or a CL to confirm cyclic ovarian activity; and palpation of the reproductive tract 
for any gross abnormalities such as uterine fluid).  
 
Oestrus synchronization and artificial insemination  
Buffaloes that were chosen for the study after clinical examination were synchronized 
by the Ovsynch-TAI program developed in cattle (Pursley et al., 1995) and previously 
applied in the Mediterranean river buffalo (Neglia et al., 2003, 2008). The program 
consists of an i.m. injection of GnRH agonist (buserelin acetate, 12 μg; Receptal®, 
Intervet, Milan, Italy) on day 0 (GnRH1), PGF2α analogue (luprostiol, 15 mg; 
Prosolvin
®
, Intervet) on day 7, and GnRH agonist on day 9 (GnRH2). Fixed-time 
artificial insemination (TAI) was performed by the same operator in all buffaloes 20 
hours after the second injection of GnRH. Because of the relatively low intensity of 
oestrous behaviour in buffaloes (Ohashi, 1994) animals were palpated per rectum and 
underwent ultrasound examination on day 10 to assess oestrous status. All animals 
with a follicle > 1.0 cm and a tonic uterus, with or without mucous vaginal discharge, 
were considered to be in oestrus. All buffaloes were given an injection of GnRH 
agonist on day 20 after TAI which is intended to reduce the incidence of late 
embryonic mortality (LEM) (Campanile et al., 2005, 2007, 2008; Rossi et al., 2014). 
 
Experimental design  
All buffaloes underwent ovarian ultrasonography examination on days 0, 2, 7, 9, 10 
and 11 of the Ovsynch-TAI program. Ultrasonography was carried out with a portable 
Sonoace Pico (Medison, Seoul, South Korea) equipped with a 7.5 MHz linear 
transducer adapted for trans rectal examination in large domestic animals. The same 
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experienced operator conducted all ultrasonography examinations. The ovarian 
features recorded were: (1) number of small, medium and large follicles; (2) diameter 
of the largest follicle and (3) presence of a CL and dimensions (length of the two 
axis). The Colour-Doppler mode was used to evaluate blood flow in the CL as 
previously reported (Russo et al., 2010; Neglia et al., 2014).  
The animals were then classified according to their responses in the Ovsynch-TAI 
program:  
 Response to GnRH1 (evaluated on day 2): positive response, ovulation of the 
follicle recorded on day 0; negative response, no ovulation. 
 Response to PGF2α (evaluated on day 10): positive response, regression of CL 
(CLs) recorded on day 7 (by assessing CL blood flow and ultrasound 
characteristics); negative response, presence of active and vascularized 
CL/CLs. 
 Response to GnRH2 (evaluated on day 11): positive response, ovulation of the 
largest follicle recorded on day 10; negative response, no ovulation. 
All animals underwent TAI on day 10 irrespective of the response to GnRH1, PGF2α 
or GnRH2. Pregnancy diagnosis was carried out on day 27 after TAI using 
ultrasonography and pregnancy was confirmed on day 45 by rectal examination. 
Buffaloes pregnant on day 27 but not on day 45 were considered to have undergone 
LEM.  
 
Progesterone assay  
Blood concentrations of P4 were measured by RIA (Niswender, 1973; Skaggs et al., 
1986) on day 0 and day 10 of the Ovsynch-TAI program and on day 10 after TAI. 
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Jugular blood samples were centrifuged at 800 x g for 15 min and blood was stored at 
-20 °C until analysed for P4. The minimum detectable amount of P4 was 2.1  0.08 
pg and the intra- and inter-assay coefficients of variation were 6.2% and 11.8%, 
respectively. 
 
Statistical analysis   
Statistical analysis was carried out by ANOVA. The factors considered in the analysis 
were: the number of follicles in each size category; the dimensions and area of large 
follicles; and the presence and area of the CL. Chi- square analysis was performed to 
compare pregnancy rates in animals categorized according to the response to different 
stages of the Ovsynch-TAI program. Logistic regression analysis models were used to 
evaluate the factors that affected the odds ratio for both the response to GnRH1 and 
pregnancy outcome. For the former (response GnRH1), the models incorporated the 
effects of all the parameters recorded on day 0: number of small, medium and large 
follicles, follicle area, CL presence and area, and P4 concentration. For pregnancy 
outcome, the response to GnRH1, and P4 concentrations on day 0 of the Ovsynch-
TAI program and on day 10 after TAI, were considered. The number of small, 
medium and large follicles, follicle area, CL area, and P4 concentration on day 0 and 
day 10 of the Ovsynch-TAI program and on day 10 after TAI were used as continuous 
variables, whereas other factors were used as dummy variables. 
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Results 
 
Response to the first GnRH (GnRH1) administered on day 0 
The injection of GnRH on day 0 of the Ovsynch-TAI program induced ovulation in 
70/116 (60.3%) buffaloes. Buffaloes that ovulated had a similar number of small, 
medium and large follicles as buffaloes that did not ovulate (7.99 ± 0.4 and 7.72 ± 
0.6; 0.94 ± 0.1 and 0.84 ± 0.1; 1.17 ± 0.1 and 1.02 ± 0.1; respectively). Buffaloes that 
ovulated had a smaller (P < 0.05) area of the largest follicle than buffaloes that did not 
ovulate (Table 7). There was no difference in the occurrence of a follicle > 0.75 cm
2 
between buffaloes that ovulated and those that did not ovulate (Table 7). Buffaloes 
that ovulated had a larger (P < 0.05) CL than buffaloes that did not ovulate (Table 7). 
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Table 7. Ovarian features recorded on day 0 of the Ovsynch-TAI Program and 
response to the first GnRH (GnRH1) evaluated on day 7 in river buffaloes undergoing 
an Ovsynch-TAI program. Results are presented as proportions or mean ± SE. 
 
Response 
to GnRH1 
Number of 
buffaloes 
 
Follicle 
diameter 
> 0.75 mm 
 
Follicle 
area 
> 0.75 cm
2
 
 
N° of CL 
(%) 
 
CL 
(area, cm
2
) 
Ovulation 
 
70/116 
(60.3%) 
 
60/70 
(85.7%) 
1.1 ± 0.1
a
 
54/70 
(77.1%) 
1.8 ± 0.1
a
 
No 
ovulation 
 
46/116 
(39.7%) 
 
38/46 
(82.6%) 
1.3 ± 0.1
b
 
34/46 
(73.9%) 
1.5 ± 0.1
b
 
 
a, b
 values within columns with a different superscript differ (P < 0.05) 
 
Response to PGF2α administered on day 7 and status of the CL 
At day 7 of the Ovsynch-TAI program, 101/116 (87.1%) buffaloes had a vascularized 
CL. A greater (P<0.01) proportion of buffaloes that ovulated after GnRH1 on day 0 
had a vascularized (functional) CL on day 7 compared with buffaloes that did not 
ovulate (69/70=98.5% and 32/46 =69.6%, respectively). There was no difference in 
CL area at day 7 between buffaloes that ovulated and those that did not ovulate after 
GnRH1 (1.5 ± 0.1 cm
2
 and 1.5 ± 0.1 cm
2
, respectively). Despite of the number of 
buffaloes that showed CL on day 0 of the Ovsynch-TAI Program, the response to 
PGF2α was evaluated on those that showed CL on day 7. At day 10, the number of 
buffaloes that had not undergone CL regression was less (P < 0.05) for buffaloes that 
ovulated after GnRH1 than for buffaloes that did not ovulate (1/69 =1.4% and 5/32 = 
15.6%, respectively).  
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Response to the second GnRH (GnRH2) and AI 
At day 10 of the Ovsynch-TAI program, 106/116 (91.4%) buffaloes were judged to be 
in oestrus based on the criteria of a tonic uterus and follicle > 1.0 cm. A higher (P < 
0.05) proportion of buffaloes that ovulated after GnRH1 was in oestrus compared with 
buffaloes that did not ovulate (67/70 = 95.7 % and 39/46 = 84.8 %, respectively). The 
area of the preovulatory follicle was greater (P < 0.01) for buffaloes that ovulated 
after GnRH1 than buffaloes that did not ovulate (1.5 ± 0.1 cm
2
 and 1.4 ± 0.1 cm
2
, 
respectively). After GnRH2 on day 10, a higher (P < 0.05) ovulation rate was 
observed for buffaloes that had ovulated after GnRH1 than for buffaloes that did not 
ovulate (65/70 (92.8%) and 37/46 (80.4%), respectively).   
 
Pregnancy to AI 
The pregnancy to AI (P/AI) was greater (P < 0.01) at both day 27 and day 45 in 
buffaloes that ovulated after GnRH1 compared with buffaloes that did not ovulate 
(Table 8). There was also a tendency for lower LEM in buffaloes that ovulated after 
GnRH1 (Table 8) Regardless of the response to GNRH1, the area of the preovulatory 
follicle was greater (P < 0.01) in pregnant buffaloes at day 27 compared to non-
pregnant. All buffaloes that failed to respond to PGF2α on day 7 and/or GnRH on day 
10 were not pregnant at day 27.  
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Table 8. Pregnancy to AI (P/AI) on day 27 and day 45 after TAI and occurrence of 
late embryonic mortality (LEM) in buffaloes that ovulated or did not ovulate after the 
first GnRH (GnRH1) administered on day 0 in an Ovsynch-TAI program. 
 
Pregnancy to AI (P/AI) 
Response to GnRH1 Pregnant day 27 Pregnant day 45 LEM 
Ovulation 
(70/116) 
53/70 
(75.7%)
 a
 
46/70 
(65.7%)
 a
 
7/53 
(13.2%) 
No ovulation 
(46/116) 
14/46 
(30.4%)
 b
 
10/46 
(21.7%)
 b
 
4/14 
(28.6%) 
Total 
(116/116) 
67/116 
(57.8%) 
56/116 
(48.3%) 
11/67 
(16.4%) 
 
a,b
 values within columns with a different superscript differ (P < 0.01) 
 
The logistic regression analysis showed that pregnancy outcome at day 27 was 
influenced by the number of small follicles at the time of GnRH1 (odds ratio = 1.248, 
P < 0.01), P4 concentrations on day 10 after TAI (odds ratio = 2.201, P < 0.01), and 
the response to GnRH1 (odds ratio = 7.564, P < 0.001). Pregnancy outcome at day 45 
was also influenced by the number of small follicles at the time of GnRH1 (odds ratio 
= 1.305, P < 0.01), P4 concentrations on day 10 after TAI (odds ratio = 2.046, P < 
0.05), and the response to GnRH1 (odds ratio = 9.037, P < 0.001). The response to 
GnRH1 was only influenced by P4 concentrations at day 0 (odds ratio = 1.543, P < 
0.05).  
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Progesterone assay 
Buffaloes that ovulated after GnRH1 had higher (P < 0.05) blood concentrations of P4 
at the start of the Ovsynch-TAI program (day 0) than buffaloes which did not ovulate 
(Table 9). For all buffaloes, those pregnant at day 45 had higher (P < 0.05) blood 
concentration of P4 both at day 0 and at day 10 after TAI (Table 10). 
 
 
Table 9. Blood progesterone concentrations in river buffaloes undergoing an 
Ovsynch-TAI program. Progesterone was determined at day 0 (first GnRH, GnRH1) 
and day 10 (TAI) of the program and at day 10 after TAI. 
Progesterone (ng/mL) 
 
Response to 
GnRH1 
 
n 
day 0 
(GnRH1) 
day 10 
(TAI) 
day 10 after 
TAI 
Ovulation 
 
70/116 
(60.3%) 
 
1.8 ± 0.2
a
 0.2 ± 0.0 2.1 ± 0.1 
No ovulation 
 
46/116 
(39.7%) 
 
1.3 ± 0.2
b
 0.2 ± 0.0 1.8 ± 0.2 
 
Total 
 
116 1.6 ± 0.1 0.2 ± 0.0 2.0 ± 0.1 
 
a,b
 values within columns with a different superscript differ (P < 0.05) 
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Table 10. Blood progesterone concentrations at different stages of an Ovsynch-TAI 
program for river buffaloes that were pregnant and not pregnant at day 45 after TAI. 
Progesterone was determined at day 0 (first GnRH, GnRH1) and day 10 (TAI) of the 
program and on day 10 after TAI. 
 
Progesterone (ng/mL) 
 
Pregnancy 
status at day 
45 
 
n 
day 0 
(GnRH1) 
day 10 
(TAI) 
day 10 after 
TAI 
 
Pregnant 
 
56 1.9 ± 0.2
a
 0.2 ± 0.1 2.2 ± 0.1
a
 
 
Not pregnant 
 
60 1.4 ± 0.2
b
 0.2 ± 0.1 1.8 ± 0.1
b
 
 
a,b
 values within columns with a different superscript differ (P < 0.05) 
 
Discussion 
 
In the present study, only 10.3% of buffaloes did not ovulate after the second GnRH 
(GnRH2) and 90% were judged to be in oestrus at the time of TAI. These responses in 
the Ovsynch-TAI program were not, however, predictive of pregnancy to AI (P/AI). 
The most notable predictor of the likelihood of P/AI was whether buffaloes ovulated 
after the first GnRH (GnRH1) at the start of the program. The largest follicle in 
buffaloes that ovulated after GnRH1 was smaller than the largest follicle in buffaloes 
that did not ovulate. This finding was interpreted to suggest that buffaloes that 
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ovulated were at early stages of the oestrous cycle (day 5 to 9). Ovulation after 
GnRH1 was followed by the development of a CL that was responsive to PGF2α on 
day 7, the selection and growth of a dominant follicle that ovulated after GnRH2 on 
day 10, and the release of a newly matured oocyte that was competent to undergo 
fertilization and embryonic development. The present findings in lactating river 
buffaloes are consistent with the relationship between the follicular response to 
GnRH1 and pregnancy outcome observed in lactating dairy cows (Vasconcelos et al., 
1999; Bello et al., 2006; Carvalho et al., 2015) and dairy heifers (Moreira et al., 2000) 
subjected to the Ovsynch-TAI program. It can be concluded from the present findings 
in Mediterranean river buffaloes and from the studies in dairy cattle that pregnancy 
outcome in the Ovsynch-TAI program is optimized when treatment starts early in the 
oestrous cycle (day 5 to 9) and animals undergo ovulation in response to GnRH1. 
The ovulation rate after GnRH1 observed in the present study was similar to that 
reported previously for the river buffalo (Baruselli et al., 2003, 2007; Campanile et 
al., 2008). The present study has extended these earlier reports by demonstrating the 
fundamental importance of ovulation to GnRH1 in the P/AI outcome in river 
buffaloes subjected to an Ovsynch-TAI program. As noted above, ovulation to 
GnRH1 would have been followed by the formation of a CL and the emergence of a 
new follicular wave (Baruselli et al., 2007) that optimized the subsequent responses to 
PGF2α on day 7 and GnRH2 on day 10. Indeed, buffaloes that ovulated after GnRH1 
had a higher CL regression rate after PGF2α on day 7 and higher ovulation rate after 
GnRH2 on day 10 (Bello et al., 2006). In cattle, ovulation to GnRH1 reduces 
significantly the likelihood of a persistent dominant follicle that is associated with 
lower fertility (Tatcher et al., 1996; Austin et al., 1999; Wiltbank et al., 2011). 
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Persistent dominant follicles can enter atresia (Bello et al., 2006) and lose the ability 
to respond to GnRH2 in an Ovsynch-TAI program (Wiltbank et al., 2014).  
In river buffaloes, follicular deviation occurs at about 7.2 mm and ovulatory capacity 
is acquired at around 8.0 to 8.5 mm (Campanile et al., 2008; Gimenes et al., 2011). 
Buffaloes that ovulated after GnRH1 in the present study tended to have a smaller 
follicle size than buffaloes that did not ovulate. This finding was interpreted to 
suggest that buffaloes which did not ovulate to GnRH1 were outside the day 5 to 9 
window of the oestrous cycle and at later stages of follicular waves. This would be 
consistent with observations in dairy cows treated with the Ovsynch-TAI program 
(Pursley et al., 1995; Vasconcelos et al., 1999). The variability in stage of the oestrous 
cycle at the time of GnRH1 was the basis for the development of the Double-Ovsynch 
pre-synchronization treatment in dairy cows (Aires et al., 2013; Giordano et al., 
2013). 
Buffaloes pregnant at day 45 had higher blood P4 concentrations at the start of the 
Ovsynch-TAI program (day 0) and also at day 10 after TAI. Unexpectedly, the P4 
levels on Day 0 of the Ovsynch-TAI Program did not influence the response to 
GnRH1. Higher concentrations of P4 at the start of the program would ensure an 
adequate environment for optimal follicular development and fertility (Bisinotto et al., 
2010; Wiltbank et al., 2012; Pursley and Martins, 2012). Likewise, it has been shown 
in river buffaloes that P4 concentrations after TAI have an important bearing on early 
and late embryonic mortality (Campanile et al., 2005; Neglia et al., 2012; Balestrieri 
et al., 2013; Strazzullo et al., 2014). The positive relationship between P4 
concentrations on day 0 and P/AI outcome in the present study was not consistent 
with observations in dairy cows subjected to the Ovsynch-TAI program. In lactating 
dairy cows, reduced P4 concentrations at day 0 are associated with a higher ovulation 
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rate to GnRH1 and increased P/AI (Carvalho et al., 2015; Giordano et al., 2012a, 
2012b). It was reported that blood P4 concentrations > 3.0 ng/mL at day 0 suppressed 
the LH response to GnRH1 and lowered the ovulation rate in dairy cows (Giordano et 
al., 2012a). To investigate this further, cows were treated with a low dose of PGF2α 
two days before the start of an Ovsynch-TAI program (Carvalho et al., 2015). Cows 
pre-treated with PGF2α had lower P4 concentrations at day 0 and showed a higher 
ovulation rate to GnRH1 and higher P/AI (Carvalho et al., 2015). Although all 
buffaloes received GnRH on day 20 after TAI to increase P4 secretion (Campanile et 
al., 2010, 2016), a tendency to higher LEM was observed in buffaloes that did not 
ovulate after GnRH1. In lactating dairy cows, the beginning of Ovsynch-TAI program 
on days 5 to 9 of the oestrous cycle was associated with the highest P/AI and the 
lowest pregnancy loss (Vasconcelos et al., 1999). The common finding in river 
buffaloes and dairy cows of a direct relationship between ovulation after GnRH1 and 
pregnancy outcome strongly indicates that the new dominant follicle that ovulates 
after GnRH2 releases an oocyte that has optimal capacity to undergo fertilization and 
establish pregnancy.    
In summary, the present study has provided conclusive evidence of the importance of 
ovulation after GnRH1 to the pregnancy outcome in Mediterranean river buffaloes 
undergone Ovsynch-TAI program. Ovulation after GnRH1 administered on day 0 
optimizes the response of the CL to PGF2α on day 7 and the response of the 
preovulatory follicle to GnRH2 on day 9, increasing the likelihood of pregnancy to 
TAI.  
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Experiment 4 
Analysis of factors involved in the failure of ovum capture in 
superovulated buffaloes 
 
Materials and Methods  
The Ethical Animal Care and Use Committee of the Federico II University of Naples 
approved the experimental design and animal treatments. 
 
Experimental design 
The study was carried out in Southern Italy (latitude 40.5° - 41.5° N and longitude 
13.5 - 15.5) during autumn, i.e. the breeding season, on 35 multiparous Italian 
Mediterranean Buffalo cows with a mean weight and age of 556.7 ± 13.8 kg and 5.6 ± 
0.3 years, over four replicates. Animals were randomLy divided into two groups: a 
group (n = 25) was synchronized by Ovsynch (as described in details in Experiment 
3) and another group (n=10) was superovulated as described below. Based on the 
results of Experiment 3, only synchronized animals that ovulated after the first GnRH 
in the Ovsynch protocol (n=14) were chosen as a control group and slaughtered 18 
hours after the last GnRH, just before ovulation. According to Experiment 1, 
buffaloes with an antral follicle count ≥ 12 follicles, i.e. good donors (n =5), and < 12 
follicles, i.e. bad donors (n = 5), were superovulated. In these subjects ovulation was 
also induced by administering GnRH at the end of the superovulatory treatment and 
animals were sacrificed in the peri-ovulatory period, i.e. 18 h after GnRH 
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administration. At slaughter, blood samples were taken for hormone analyses in both 
groups. All blood samples were separated using centrifugation at 4°C, 800 g for 10 
min, and stored at −20°C until the analysis. Moreover, ovaries and oviducts of 
animals of both groups were recovered individually and transported to the laboratory 
in physiological saline supplemented with 150 mg/L kanamycin at 30-35°C. 
  
Multiple ovulation schedule  
According to the results of the experiment 2, the animals were synchronized by a 
double injection of 0.524 mg of PGF2a analogue (Cloprostenol, Estrumate®, 
Schering-Plough Animal Health, Milan, Italy) 12 days apart. Ovulation was induced 
by administering GnRH analogue (buserelin acetate,12 mg; Receptal; Intervet, Milan, 
Italy) 2 days after the last PGF2a and the following day, at the presumptive time of 
ovulation, a progesterone releasing intravaginal device (PRID®, Ceva Vetem SpA, 
Milan, Italy) was inserted (day 0). Then, superovulation treatment, consisting in 400 
mg FSH (Folltropin®, Bio98, Milan, Italy) given in decreasing dosages for 4 
consecutive days started on day 8. Briefly, the scheme was: 80 mg on day 8, 60 mg on 
day 9, 40 mg on day 10 and 20 mg on day 11, given twice daily. On day 10 (72 and 
84 h after initiating gonadotrophin treatment) buffaloes were administered 0.524 mg 
PGF2a twice (12 h apart) for inducing luteolysis and PRID was removed. On day 12 
animals received GnRH analogue to induce ovulation and on day 13, precisely at 18 h 
after GnRH, were sacrificed at a local abattoir.  
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Collection of follicular fluid and granulosa cells 
At the laboratory, the presumptive dominant follicles (diameter > 0.7 cm) in both 
synchronized and superovulated animals were measured: follicle size was assessed by 
measurement of the two perpendicular diameters with a millimetre scale. The FF of 
the dominant follicle was aspirated by a syringe with a 21-gauge needle, poured into a 
petri dish for a quick search of the oocyte, recovered in a vial and centrifuged at 600 
X g for 10 min to separate the follicular fluid and the GCs. After centrifugation, the 
FF recovered was directly snap frozen and stored at - 80°C until hormonal assay 
determination, while the GCs-containing pellet was previously washed with 
PBS+PVA (0.1%), centrifuged again at 600 X g for 10 min, then snap frozen in liquid 
nitrogen and stored at -80°C until RNA isolation. 
 
Evaluation of oocyte quality and maturation status 
The FF recovered from the dominant follicles of synchronized and superovulated 
buffaloes was inspected under a microscope for the presence or absence of the COC. 
For each run, the recovery rate, i.e. the percentage of COCs in relation to the aspirated 
follicles, and the percentage of oocytes showing an appropriate cumulus expansion 
were recorded. The cumulus-oocyte complexes recovered were scored for quality on 
the basis of morphological features according to our classification (Di Francesco et 
al., 2011). Oocytes were stripped of the cumulus cells by gentle pipetting, allocated on 
a clean slide and fixed in absolute ethanol overnight. Then oocytes were stained with 
DAPI to evaluate the nuclear status using a Nikon Diaphot 300 inverted microscope 
equipped with fluorescence filters.  
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Collection of oviduct samples 
At the laboratory, both oviducts of each synchronized and superovulated animal were 
trimmed free of tissue. According to anatomy, the oviduct was divided into four parts: 
fimbriae, infundibulum, ampulla and isthmus. Tissues from fimbriae were directly 
frozen into liquid nitrogen and stored at −80°C until RNA isolation. The 
infundibulum, ampulla and isthmus of both oviducts were placed into a Petri dish, 
washed three times with physiological saline and then opened longitudinally. Once 
opened they were gently scraped with a blade and flushed with 500 μL PBS+PVA 
(0.1%), to recover epithelial cells. Cells were centrifuged twice at 600 X g for 10 min, 
PBS was removed and the pellet was snap frozen and stored at −80°C until RNA 
isolation.  
 
Hormonal assay  
Oestradiol and progesterone were determined by a solid-phase microtiter RIA. In 
brief, a 96-well microtitre plate (OptiPlate, Perkin-Elmer Life Science, Boston, MA, 
USA) was coated with goat anti-rabbit γ-globulin serum (diluted 1:1000 in 0.15 mM 
sodium acetate buffer at pH 9) and incubated overnight at 4°C. The plate was then 
washed twice with RIA buffer (pH 7.4) and incubated overnight at 4°C with 200 μL 
of the antibody serum diluted 1:8.000 for P4 and 1:80.000 for 17-β-oestradiol. After 
washing the plate with RIA buffer, standards (5–200 pg/well), the quality control 
extract, the test extracts and the tracer (progesterone [1,2,6,7-3H (N)] or 17-β-
oestradiol [2,4,6,7,16,17-3H (N)]; PerkinElmer Life Sciences Inc., Boston, MA, USA) 
were added, and the plate was incubated overnight at 4°C. Bound hormone was 
separated from free hormone by decanting and washing the wells in RIA buffer. After 
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the addition of 200 μL/well scintillation cocktail (Microscint 20, Perkin- Elmer Life 
Sciences), the plate was counted using a beta-counter (Top-Count, Perkin-Elmer Life 
Sciences).  
The cross-reactivity of the anti-progesterone antibody with other steroids was as 
follows: 11 β-OH-progesterone, 46%; 17 α-OH-progesterone, 0.4%; 20 α-OH-
progesterone, 0.04%; testosterone, 0.08%; cortisol, <0.01%; estradiol-17-β, <0.01%; 
estradiol-17-α, <0.01%; and oestrone, <0.01%. The cross-reactivity of the anti-17-β-
oestradiol antibody with other steroids was as follows: 17-α-oestradiol, 0.62%; 
oestrone, 1.5%; estrone-3-sulphate, 0.3%, estriol, 0.8%; estriol-3-sulphate. 0.03%.  
P4 Intra- and inter-assay coefficients of variation were 7.3% and 12%, respectively. 
The minimum detectable amount of P4 was 0,8 pg. Intra and inter-assay coefficients 
of variation for 17-β-oestradiol were 7.0 % and 11.8%, respectively. The minimum 
detectable amount of P4 was 0.91 pg. 
 
RNA Isolation and detection  
Total RNA was purified for each sample (for fimbriae 5 mg of tissue were used) by 
using RNeasy Mini Kit (Qiagen, 74104, Germany). The protocol was performed 
according to the manufacturer’s instructions. The final elution step was repeated and 
the purified total RNA was subsequently stored at -80°C. Quantity of the total RNA 
samples was evaluated by Thermo Scientific™ NanoDrop™ 2000 
spectrophotometers. The level of degradation was analysed using agarose 
electrophoresis. Samples with Clear 28S and 18S ribosomal RNA bands and band 
intensities of 28S:18S close to two were chosen in this study. 
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cDNA synthesis  
One μg of detected RNA was used to synthesize first-strand cDNA using the 
QuantiTect® Reverse Transcription Kit (Qiagen, 205311, Germany) according to the 
manufacturer's protocol. To eliminate genomic DNA contamination in RNA samples, 
the gDNA elimination reaction was performed using 2 μL of gDNA wipe-out buffer, 
1 μg template RNA and RNase-free water to adjust the final volume to 14 μL at 42°C 
for 2 min. Reverse transcription was carried out in a total of 20 μL reaction containing 
1 μL Quantiscript Reverse Transcriptase, 4 μL Quantiscript RT buffer with Mg2+ and 
dNTPs, 1 μL RT Primer Mix and 14 μL Template RNA (Entire genomic DNA 
elimination reaction) at 42°C for 15 min and 95°C for 3 min. All steps were 
performed on ice. The cDNA was stored at -20°C until real-time PCR analysis.  
 
Real-Time PCR analysis  
Real-time quantitative PCR reactions were run using QuantiFast® SYBR® Green 
PCR Kit (Qiagen, 204054, Germany) on BIORAD CFX Manager Machine. The ER1, 
PGR, VEGF, FLK1 and LHR, FSHR, as well as ACTB primers (shown in Table 11) 
were designed by Primer Premier 5 software and synthesized by Eurofins Genomics. 
Samples were prepared according to the manufacturer’s instructions. A total reaction 
volume of 20 μL contained 10 μL Master Mix, 2 μL primers and 8 μL diluted cDNA 
(1:30). The samples were then centrifuged at 1000 X g at 4°C for 1 min.  
All cDNA samples were amplified under the following conditions: 95°C for 5 min, 40 
cycles at 95°C for 10 s and 60°C for 30 s for LHR and FSHR, 95°C for 5 min, 40 
cycles at 95°C for 10 s and 64°C for 30 s for PGR, FLK1 and FLT1 and 95°C for 5 
min, 35 cycles at 95°C for 10 s and 64°C for 30 s for VEGF and ER1. The data were 
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subsequently quantified according to the comparative cycle threshold (CT) method 
and expression levels were presented as 2-ΔCT normalized to the ACTB housekeeping 
gene. 
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Table 11. Primers used in this study for Real time PCR. 
Gene Sequence (5'to3') Accession No. Product size (bp) 
VEGF 
F aaaacacagactcgcgttgc 
NM_001316956.1 248 
R 
gcctcctcttccttcatgtca 
FLK1 
F gcggccaatgtgtctgcttt 
XM_006058316.1 140 
R acattctcctgctcggtggg 
FLT1 
F cacctgccttctccgaggac 
 XM_006078571.1 
250 
R agtgaggccttgggtttgct 
PGR 
F gatgctatattttgcgcctga 
XM_006057027.1 
266 
R ctcctttttgcctcaaacca 
ER1 
F aatctgccaaggagactcgc 
XM_006080203.1 
240 
R tccgtatcccgcctttcatc 
FSHR 
F aaacgtgttctccaacctgc 
NM_001290962.1 157 
R cttgtgaacagctggcaagt 
LHR 
F gctctacctgctgctcattg 
XM_006078413.1 216 
R ttcagtcgcagcttttggtc 
ACTB 
F atgatgatattgccgcgctc 
NM_001290932.1 216 
R cgtgctcaatggggtacttg 
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Statistical analysis  
Differences in morphological follicular parameters, as well as in the concentration of 
progesterone and oestradiol both in plasma and in follicular fluid were analysed by 
ANOVA, using Least Significant Difference (LSD) as a post-hoc test. Differences in 
the recovery rate and in the percentage of oocytes showing cumulus expansion were 
analysed by Chi Square Test.  
The follicular parameters and steroid profile in FF of follicles containing a properly 
expanded oocyte (good follicles) vs those with an unexpanded oocyte (bad follicles) 
in synchronized and superovulated animals were compared. In particular, as most of 
the follicles of synchronized animals contained an expanded oocyte, the comparison 
was carried out among the good follicles of synchronized animals and good and bad 
follicles of the superovulated counterparts, by ANOVA, using Least Significant 
Difference as a post-hoc test.  
Pearson correlation analysis was carried out to evaluate the relationship between 
steroid profile (both in FF and plasma) and the characteristics of the follicles. 
Furthermore, to evaluate the correlation between E2 and P4 concentration and gene 
expression, samples from 10 animals were used. Differences in gene expression levels 
between superovulated and synchronized animals were analysed by Student’s t test.  
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Results 
 
Response to synchronization 
Buffaloes that ovulated after the first GnRH were 14/25 (56%) and only these animals 
were chosen for the comparison with the superovulated counterparts. Interestingly, a 
high incidence of animals showed the preovulatory follicle on the right ovary 
(71.4%).    
 
Phenotypical evaluation of superovulated buffaloes 
The first important information that arose from this study is the high variation in the 
superovulatory response of the animals. In table 11 the average, as well as minimum 
and maximum values for the number and size of preovulatory follicles and steroid 
concentrations in plasma and follicular fluid (FF) in superovulated animals are 
reported. The proportion of preovulatory follicles was similar in left and right ovary 
(47.9% vs 52.1% respectively). However, in 9 out of 10 superovulated animals a 
higher percentage was recorded on the right ovary (55.5 vs 44.5; P<0.05). A high 
individual variability was also observed in the number of preovulatory follicles, that 
ranged from 3 to 29, and in the recovery rate (from 0 to 76.9%), as shown in Table 11. 
Moreover, the percentage of COCs with cumulus expansion was very low, but ranged 
from 0 to 100% (Table 12).  
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Table 12. Average, minimum and maximum values for the number and size of 
preovulatory follicles and steroid concentrations in plasma and follicular fluid (FF) in 
superovulated animals. 
 Mean ± SE Min Max 
n. of preovulatory follicles 14.4 ± 2.7 3 29 
Min. follicle Diameter (cm) 0.75 ± 0.05 0.6 1.0 
Max. follicle Diameter (cm) 1.10 ± 0.06 0.9 1.4 
Mean follicle Diameter (cm) 0.9 ± 0.05 0.8 1.2 
FF volume (mL) 0.6 ± 0.1 0.3 1.3 
E2 concentration (ng/mL) in FF 30.3 ± 5.9 9.1 47.7 
P4 concentration (ng/mL) in FF 71.6 ± 8.5 29.2 104.5 
E2:P4 ratio in FF 0.6 ± 0.1 0.3 1.1 
E2 in plasma (ng/mL) 15.4 ± 0.9 11.6 17.4 
P4 in plasma (ng/mL) 0.4 ± 0.04 0.3 0.5 
E2:P4 ratio in plasma 0.04 ± 0.01 0.03 0.06 
Recovery rate (%) 55.0 ± 5.6 33.3 76.9 
Oocytes with cumulus expansion 
(%) 
44.2 ± 14.8 0.0 100.0 
 
Based on the results of experiment 1, we choose good (≥ 12 follicles before the 
treatment; n=5) and bad donors (< 12 follicles before the treatment; n=5) according to 
the AFC, synchronizing the animals before starting the superovulation protocol. It is 
interesting to provide a description of the parameters recorded in superovulated 
animals divided in relation to the number of preovulatory follicles (Table 13). 
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Interestingly, the animals with a low response in terms of the number of preovulatory 
follicles had a higher (P<0.05) proportion of oocytes exhibiting a proper expansion of 
the cumulus cells, whereas no other differences were recorded. 
 
Table 13. Follicular parameters and intrafollicular steroid profile in superovulated 
animals in relation to number of preovulatory follicles, classified as good (>12 
follicles) and bad (<12 follicles) donors. 
Follicular parameters good (n=5) bad (n=5) 
 Mean ± SE Mean ± SE 
N. preovulatory follicles 20.8 ± 3.3
A
 4.5 ± 1.5
B
 
Minimum follicle Diameter (cm) 0.8 ± 0.1 0.7 ± 0.0 
Maximum follicle Diameter (cm) 1.1 ± 0.1 1.1 ±0.03 
Mean follicle Diameter (cm) 0.9 ± 0.1 0.9 ±0.0 
Follicular fluid (FF) volume (mL) 0.5 ± 0.1 0.9 ±0.4 
Oestradiol (E2) concentration (ng/mL) in FF 28.1 ± 8.0 35.9 ± 7.3 
Progesteron (P4) concentration (ng/mL) in FF 63.1 ± 8.7 92.7 ± 11.7 
E2:P4 ratio in FF 0.6 ± 0.2 0.6 ± 0.1 
Oestradiol (E2) in plasma (pg/mL) 15.6 ± 1.3 15.1 ± 0.3 
Progesteron (P4) in plasma (ng/mL) 0.4 ± 0.1 0.3 ±  0.1 
E2:P4 ratio in plasma 0.04 ±0.0 0.05 ± 0.0 
 N (%) N (%) 
Recovery rate (%) 59/104 (56.7) 5/9 (55.6) 
Oocytes with cumulus expansion (%) 15/59 (25.4)
a
 4/5 (80.0)
b
 
 
A,B
 Values with different superscripts are significantly different; P<0.01
 
a,b
 Values with different superscripts are significantly different; P<0.05 
 
Differences between synchronized vs superovulated animals 
Results regarding the morphological parameters of the follicles, the hormonal 
concentration of progesterone and oestradiol both in plasma and in follicular fluid, as 
well as the recovery rate and the proportion of oocyte with cumulus expansion in 
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synchronized and superovulated buffaloes are summarized in Table 14. No 
differences were observed between groups in both the diameter and the volume of the 
follicular fluid. However, in superovulated animals the E2 and P4 concentrations in 
FF were lower (P<0.05) than in synchronized animals, but the oestradiol: 
progesterone ratio in FF was not affected. Despite the decreased concentration of 
steroids in the FF, the plasmatic levels of both oestradiol and progesterone, as well as 
the oestradiol: progesterone ratio, were similar in the two groups. Interestingly, both 
the recovery rate (P<0.05) and the percentage of oocytes exhibiting proper cumulus 
expansion (P<0.01) decreased in the superovulated animals. The majority of oocytes 
showing cumulus expansion reached the metaphase II stage in both groups (100% and 
94.4%, respectively in synchronized and superovulated buffaloes).  
The follicular parameters and steroid profile in FF of follicles containing a properly 
expanded oocyte (good follicles) vs those with an unexpanded oocyte (bad follicles) 
in synchronized and superovulated animals are shown in Table 15. Unexpectedly, no 
differences were recorded between good and bad follicles within superovulated 
animals. However, a tendency to lower P4 values in bad follicles vs good follicles of 
SO group was observed but, due to the high SE, the difference was not significant. A 
decreased concentration of E2 and P4 was observed in both good and bad follicles of 
the SO group compared to the good follicles of the synchronized group, confirming 
the previous analysis. However, the difference found in FF P4 level between 
synchronized and superovulated animals was higher (P<0.01) when compared to the 
bad follicles rather than to good follicles (P<0.05) of SO animals. In addition, 
although the diameter of the follicles was similar in the three groups, the FF volume 
was higher (P<0.05) in the Synchronized group rather than in both SO groups. 
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Table 14. Morphological parameters of the follicles, hormonal concentration of 
progesterone and oestradiol both in plasma than in follicular fluid and recovery rate in 
Synchronized vs Superovulated animals. Data are presented as mean ± SE. 
 
Follicular parameters Synchronized (control) 
 n = 14 
Superovulated* 
n = 10 
 Mean ± SE Mean ± SE 
Minimum follicle Diameter (cm) 0.8 ± 0.04 0.8 ± 0.05 
Maximum follicle Diameter (cm) 1.2 ± 0.1 1.1 ± 0.1 
Mean follicle Diameter (cm) 1.0 ± 0.1 0.9 ± 0.05 
Follicular fluid (FF) volume (mL) 0.9 ± 0.1 0.6 ± 0.1 
Oestradiol (E2) concentration (ng/mL) in FF 63.2 ± 10.6
a
 30.3 ± 5.9
b
 
Progesteron (P4) concentration (ng/mL) in FF 130.1 ± 19.8
a
 71.6 ± 8.5
b
 
E2:P4 ratio in FF 0.65 ± 0.2 0.63 ± 0.1 
Oestradiol (E2) in plasma (pg/mL) 15.8 ± 1.0 15.4 ± 0.9 
Progesteron (P4) in plasma (ng/mL) 0.4 ± 0.1 0.4 ± 0.04 
E2:P4 ratio in plasma 0.05 ± 0.0 0.04 ± 0.0 
 N (%) N (%) 
Recovery rate (%) 12/14 (85.7)
a
 64/113 (56.6)
b
 
Oocytes with cumulus expansion (%) 9/12 (75.0)
A
 18/64 (28.1)
B
 
*Mean values were used for superovulated animals 
 
A,B
 Values with different superscripts are significantly different; P<0.01 
 
a,b
  Values with different superscripts are significantly different; P<0.05 
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Table 15. Follicular parameters and steroid concentration in follicular fluid (FF) of 
follicles containing a properly expanded oocyte (good follicles) vs those with an 
unexpanded oocyte (bad follicles) in synchronized and superovulated animals.   
 
 
 
Follicular parameter 
Synchronized 
(control) 
Superovulated* 
Good follicles 
 (n=9) 
Good follicles 
(n=18) 
bad follicles 
(n=46) 
Mean ± SE Mean ± SE Mean ± SE 
Minimum follicle Diameter (cm) 0.9 ± 0.04 0.8 ± 0.1 0.7 ± 0.03 
Maximum follicle Diameter (cm) 1.3 ± 0.1 1.1 ± 0.1 1.0 ± 0.04 
Mean follicle Diameter (cm) 1.1 ± 0.05 0.9 ± 0.1 0.9 ± 0.03 
Follicular fluid (FF) volume (mL) 0.9 ± 0.1
a
 0.5 ± 0.05
b
 0.4 ± 0.1
b
 
Oestradiol (E2) concentration (ng/mL) in 
FF 
63.6 ± 12.9
A
 30.3 ± 3.9
B
 27.2 ± 3.0
B
 
Progesteron (P4) concentration (ng/mL) in 
FF 
139.2 ± 25.7
Aa
 78.1 ± 9.6
bc
 62.4 ± 7.3
Bc
 
E2:P4 ratio in FF 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 
*Mean values were used for superovulated animals 
 
A, B
 Values with different superscripts are significantly different; P<0.01 
a, b
 Values with different superscripts are significantly different; P<0.05 
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Gene expression  
Regarding the granulosa cells, as shown in Figure 11, mRNA expression of FSHR 
was higher (P < 0.05) in superovulated group than in synchronized group, whereas no 
differences were found in LHr expression between groups. 
 
Figure 11. Relative mRNA expression of FSHr and LHr in Synchronized animals vs 
Superovulated animals 
 
a,b
  Values with different superscripts are significantly different; P<0.05 
 
 
With regard to the oviduct, decreased (P < 0.05) mRNA expression of PGR and ER1 
was observed in superovulated compared to synchronized animals, at the level of 
ampulla and infundibulum respectively, as shown in Figure 12. Moreover, the mRNA 
expression of the VEGF and the VEGF receptor FLK1, was also lower (P<0.05) in 
superovulated animals, respectively in the isthmus and ampulla (Figure 12). No 
mRNA expression of FLT1 was found in any tracts of the oviduct in both groups. 
a 
b 
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Figure 12. Relative mRNA expression of ER1, FLK1, PGR and VEGF in the oviduct of Synchronized animals vs Superovulated animals.
 
 
a,b
  Values with different superscripts are significantly different; P<0.05
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Correlation analysis 
Regardless of the treatment, the intrafollicular E2 concentration was positively correlated 
with the follicular volume (r = 0.563; P<0.01) and with the intrafollicular P4 concentration (r 
= 0.551; P<0.01). As expected, the blood E2/P4 ratio was positively correlated with blood E2 
concentration (r = 0.595; P<0.01) and negatively correlated with blood P4 concentration 
(r=0.537; P<0.01). In contrast, the intrafollicular E2/P4 ratio was only negatively correlated 
with the intrafollicular P4 concentration (r=-0.525; P<0.01). Within superovulated animals, 
the number of preovulatory follicles was not correlated to steroids concentration both in the 
FF and plasma. Interestingly, the percentage of oocytes showing cumulus expansion and the 
recovery rate were respectively positively and negatively correlated with the intrafollicular 
P4 concentration (r = 0.829 and r = - 0.760; P<0.05). 
Regardless of the treatment, the intrafollicular E2 concentration was positively correlated 
with PGR expression in the fimbria (r=0.734; P<0.05), whereas the intrafollicular P4 
concentration was positively correlated with PGR expression in fimbria, infundibulum and 
ampulla (r = 0.818 and r = 0.790, P <0.01; r = 0.642, P <0.05, respectively). The E2/P4 blood 
ratio was also positively correlated with PGR expression in fimbria, infundibulum and 
ampulla (r=0.740, P<0.05; r=0.808 and r=935, P<0.01, respectively). Regarding the gene 
expression within the oviduct a positive correlation between PGR and ER1 was found in 
infundibulum, ampulla and isthmus (r=0.851, P<0.01; r = 730, P<0.05; r = 0.675; P<0.05, 
respectively). Finally, no correlation was found within groups, probably due to the lower 
number of the samples. 
 
 
 
118 
 
Discussion 
 
The aim of this experiment was to investigate the different factors affecting the embryo 
recovery in superovulated buffaloes, and particularly to verify the hypothesis that in animals 
undergoing multiple ovulation programs a failure of ovum capture occurs. This hypothesis 
arises from the observations that the SO treatment promotes the growth of multiple follicles 
and their ovulation, as indicated by high number of CL at the moment of flushing, while the 
embryo recovery remains very poor (Zicarelli, 1997b; Baruselli et al., 1999; Carvalho et al., 
2002; Misra and Tyagi, 2007; Neglia et al., 2010). In addition, the flushing of oviducts and 
uteri of superovulated buffaloes sacrificed at different days after AI also resulted in a low 
number of embryos recovered (Carvalho et al., 2002), suggesting that the ovum transport to 
the uterus is not impaired, and hence leaving the failure in ovum capture the most likely 
hypothesis. Therefore, the question arises about which factors ensure a proper ovum pick-up 
by the oviduct. It is known that COCs, consisting of oocytes surrounded by the zona 
pellucida and their cumulus investment, are ovulated into the peritoneal or bursal cavity, 
where they are picked up by the fimbria. It follows that the appropriate epithelial cilia 
movement and contraction-relaxation of the oviduct, that are under the control of ovarian 
steroids (Wijayagunawardane et al., 1996), are fundamental on one side. On the other side, 
the cumulus expansion occurring during the oocyte maturation process and the consequent 
proper development of the extracellular matrix play a pivotal role. The study was designed to 
compare the morphological features of preovulatory follicles and oocytes, the steroid profile 
both in the FF and plasma, as well as the expression of genes involved in the cumulus 
expansion in granulosa cells and that of genes involved in contraction-relaxation of the 
oviduct between superovulated and synchronized buffaloes. It is worth reminding that, based 
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on the results of Experiment 3, the synchronized animals that ovulated after the 1
st
 GnRH 
administration were chosen as control. Within the superovulation group, a high individual 
variability was recorded in the number of preovulatory follicles (from 3 to 29), as well as in 
the recovery rate (33 to 77%) and the percentage of oocytes showing cumulus expansion (0 to 
100%). Interestingly, the animals with a low response in terms of the number of preovulatory 
follicles (on average 4.5) had a higher proportion of oocytes exhibiting a proper expansion of 
the cumulus cells compared to animals with high (on average 20.8) number of preovulatory 
follicles.  
The most interesting findings derive from the comparison between superovulated and 
synchronized animals. Unexpectedly, the size of the preovulatory follicle, in terms of 
minimum, maximum and mean diameter, as well as the volume of FF, were not different 
between the two groups. This is in contrast with a previous study where non stimulated 
bovine heifers had larger preovulatory follicles than superovulated ones (Assey et al., 1994); 
this could be probably due to the different species. More importantly, the intrafollicular 
steroid profile was altered in superovulated buffaloes, that showed a significant reduction of 
both oestradiol and progesterone. However, as both steroids decreased, the E2:P4 ratio in FF 
was not affected. The steroids concentration, and particularly P4 in the FF was higher than in 
plasma, as previously reported in other species (Aller et al., 2013). These results are in 
agreement with earlier studies in cattle, where the concentration of both oestradiol and 
progesterone in superovulated follicles was also lower than that recorded in the preovulatory 
unstimulated follicles (Assey et al., 1994; Aller et al., 2013; Fortune and Hansel, 1985). It is 
speculated that the preovulatory follicles of stimulated animals may be in early atresia and the 
low levels of E2 in FF may reflect their lack of aromatase activity (Aller et al., 2013). In 
contrast, higher levels of both E2 and P4 were reported in superovulated sheep but at a 
different collection time, i.e. before the LH surge (o’ Callaghan et al., 2000). Unexpectedly, 
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the decreased concentration of E2 and P4 in the FF did not result in a reduction of the steroids 
in plasma. It was previously speculated that the failure in the ovum pick-up by the fimbria in 
buffalo may be due to high levels of E2 and E2:P4 ratio, as well as to prolonged rise of E2, 
enhancing the turgidity of the genital tract (Misra et al., 1998). In fact, a poorer recovery of 
ova was recorded in animals showing increased and prolonged E2 in blood. In contrast, in our 
study the E2 and E2: P4 ratio in plasma of superovulated buffaloes were similar to those 
recorded in synchronized buffaloes and no variation was observed in relation to the number 
of preovulatory follicles. However, as hormones were measured in the peri-ovulatory period, 
after the LH surge induced by GnRH, it is not possible to rule out that E2 levels were higher 
at earlier times in FSH-stimulated buffaloes. Nevertheless, the decreased concentration of 
steroids in the FF in the peri-ovulatory period may impair the process of ovum capture by the 
oviduct. Interestingly, a reduced mRNA expression of the steroid receptors PGR and ER1 in 
the oviduct of superovulated buffaloes was also observed. Our results are in disagreement 
with those reported in an earlier trial in cattle, in which superovulation, associated with 
higher circulating steroids, did not influence the PGR and ER1 pattern within the oviduct 
(Valle et al., 2007). The decreased expression of ER1 in the oviduct may be accounted for by 
the lower E2 concentration found in the FF. In fact, it is known that under natural oestrous 
cycles E2 stimulates the production of both PGR and ER1 in cattle (Ulbrich et al., 2003). 
However, P4 is known to inhibit its own receptor; indeed, negative correlations were reported 
between PGR and circulating P4 in cattle (Valle et al., 2007). In contrast, in the present study 
the intrafollicular P4 concentration was positively correlated with PGR expression in fimbria, 
infundibulum and ampulla, whereas no relationship was observed with plasma P4 levels. In 
addition, the expression of PGR was positively associated with that of ER1 in infundibulum, 
ampulla and isthmus.  
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Furthermore, in the present study we investigated the VEGF system, that is under the control 
of ovarian steroids (Wijayagunawardane et al., 2005), known to play a role in the relaxation-
contraction of the oviduct. Interestingly, the mRNA expression of both the VEGF and its 
receptor FLK1 significantly decreased in the oviduct of superovulated buffaloes. 
Unexpectedly, the expression of VEGF receptor FLT1 was not found in any tract of the 
oviduct in both groups. This could be due to the use of primers designed for bovine, as the 
buffalo genome has still not been completely sequenced. In the female reproductive tract, 
VEGF is involved in follicular development and steroids synthesis (Gordon et al., 1996), CL 
formation and maintenance (Berisha et al., 2000), CL vascularisation (Neglia et al. 2015) 
endometrial vascular growth and permeability (Meduri et al., 2000), and foetal development 
and placental function (Cheung, 1997). In addition, the higher expression of the VEGF 
system in human and bovine oviducts (Gordon et al., 1996; Lam et al., 2003, 2004; Gabler et 
al., 1999) during the peri-ovulatory period suggests a critical role also during early 
reproductive events, such as the ovum capture and transport within the oviduct. It is known 
that the maximum contractile activity of the bovine oviduct (Ruckebusch and Bayard, 1975; 
Bennett et al., 1988), as well as the highest VEGF content and expression of VEGF receptors 
(Gabler et al., 1999) are recorded during the peri-ovulatory period. Wijayagunawardane et al 
(2005), using cultured bovine oviductal cells as a model, demonstrated that VEGF stimulates 
the synthesis of contraction-relaxation related factors, such as PGE2, PGF2a and ET-1. 
Moreover, a combined treatment of VEGF with LH, E2 and P4 increased the mRNA 
expression of VEGF and its receptors. It is therefore likely that the decreased expression of 
VEGF and FLK1 in the oviduct of superovulated buffaloes results from the reduced steroid 
levels found in the FF. It has been hypothesized that in the peri-ovulatory period the LH 
surge, the increased E2 levels and basal P4 levels up-regulate the VEGF system that in turn 
enhances the production of contraction-relaxation related factors. This may allow the ovum 
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pick-up and a rapid transport to the fertilization site. After ovulation VEGF switches over its 
own production, ensuring the embryo to reach the uterus at the proper time. Our results taken 
together suggest that in superovulated buffaloes the contraction-relaxation of the oviduct may 
be impaired, and that the lower contractility may interfere with the ovum capture. 
Nevertheless, the decreased percentage of oocytes with cumulus expansion recorded in the 
superovulated buffaloes indicates that an inappropriate oocyte maturation may also play a 
critical role. Indeed, in case of failure of cumulus expansion a less developed extracellular 
matrix could not ensure a perfect adhesion with the oviduct. If there is not a correct adhesion 
degree between the matrix and the cilia, the COC cannot enter the oviduct (Lam et al., 2000). 
Normally, the COC is too large to pass through the oviduct ostium (Talbot et al., 2003) thus, 
to move into the infundibulum, it would, by the action of the cilia, churns for several minutes, 
to compact the extracellular matrix and consequently reduce its diameter (Talbot et al., 1999). 
Using an in vitro model for assessing COC pick-up in the hamster it was demonstrated that 
expanded COCs are picked up at the normal rate, whereas unexpanded COCs, which had 
cumulus cells but not cumulus matrix, failed to adhere to the infundibulum and were not 
picked up at all (Huang et al., 1997). Interestingly, when unexpanded COCs were placed in 
the ostium, they remained in place and were not picked up even though cilia were beating 
normally. It is known that the both the adhesion of cumulus cells to the oocyte and the degree 
of cumulus expansion following maturation are lower in buffalo than in cattle (Gasparrini 
2000). It follows that the extracellular matrix in this species is also less developed. However, 
in the present study most of the COCs recovered in superovulated animals were unexpanded 
and at the GV stage, in contrast to what observed in synchronized buffaloes. It was reported 
in cattle that multiple ovulation treatment shortens the follicular phase of the oestrous cycle, 
due to the decreased interval between prostaglandin administration and LH surge (Dieleman 
and Bevers 1987, Merton et al., 2003). Likewise, superovulated buffaloes undergo oestrus 
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earlier than unstimulated buffaloes (Beg et al., 1997). A shortened follicular phase may result 
in inappropriate time for the oocyte to complete the maturation process, accounting for the 
lower proportion of expanded oocytes found in superovulated buffaloes. A high degree of 
asynchrony between the oocyte and follicular status shortly before expected time of ovulation 
(60 h after PG) was previously reported in superovulated cattle (Merton et al., 2003). The 
proportion of oocyte lacking an expanded cumulus varied between 16% (when COCs were 
collected by ovariectomy) and 40% (when COCs were recovered by OPU), and only 3% of 
unexpanded COCs developed into embryos compared to 42% of the expanded COCs (Merton 
et al., 2003). In our work the percentage of unexpanded COCs was much higher in the 
superovulatory group than in their synchronized counterpart, confirming the occurrence of 
asynchrony between the oocyte and the follicular maturation status. Unexpectedly, when 
follicles with expanded or unexpanded oocytes from superovulated buffaloes were compared, 
no differences were recorded both in terms of follicular size and intrafollicular steroid profile. 
However, the intrafollicular P4 concentration within superovulated buffaloes was positively 
correlated with the percentage of oocytes with cumulus expansion and negatively correlated 
with the recovery rate. It is therefore hypothesized that high intrafollicular P4 levels results in 
a greater expansion of cumulus cells and a greater viscosity of the FF, reducing the recovery 
rate.  
In the present study the mRNA expression of LHR in granulosa cells was similar in 
synchronized and superovulated buffaloes. In contrast, the mRNA expression of FSHR in 
granulosa cells was higher in superovulated buffaloes, despite the lower oestrogen levels in 
FF. It is known that oestrogen increases follicular expression of both FSH and LH receptors 
in rat granulosa cells (Richards et al., 1976, 1979). It was hypothesized that oestrogen 
synergizes with FSH and exogenous cAMP to increase the number of FSH receptors. 
However, other studies reported that oestrogen by itself has no effect on the distribution or 
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number of FSHRs or affinity of FSH binding to granulosa cells (Richards, 1980; Mineghisi et 
al., 1996). It is worth pointing out that, as the time of collection in our study was at the peri-
ovulatory period, we could not detect an earlier increase of oestradiol levels probably due to 
the gonadotrophin treatment. It is likely that the superovulation treatment with exogenous 
FSH resulted in the up-regulation of FSHR that persists until the peri-ovulatory period. In line 
with this hypothesis, effects of FSH have been observed on its own receptor mRNA in the 
mouse ovary. Treatment of mice with in vivo eCG stimulation increased the transcription 
(Yaron et al., 1998) of all four FSHR transcripts and this is associated with an increase in 
FSH binding (LaPolt et al., 1992). Mineghisi et al (1996), using an in vitro model with 
granulosa cells from oestrogen-treated immature rats, reported a transient decrease after 2-6 h 
followed by a recovery of FSHR mRNA after FSH treatment. After 12-60 h from the FSH 
treatment the FSHR mRNA levels were similar to the pre-treatment levels, preventing the 
decline observed in controls not receiving FSH. Nowadays it is still uncertain how FSH 
regulates its own receptors, with earlier reports of both up- and down-regulation of ligand 
binding after treatment with FSH (Richards, 1980). The influence of FSH is indeed dose and 
time dependent and may also depend on the species, the model used and the stage of 
folliculogenesis.  
In summary, the results of this experiment demonstrated that the intrafollicular concentration 
of both oestradiol and progesterone in the preovulatory follicles decreases in superovulated 
compared to the synchronized buffaloes. In addition, the recovery rate and the percentage of 
oocytes exhibiting an appropriate cumulus expansion were reduced in stimulated animals. 
Finally, in superovulated buffaloes a decreased expression of both ER1 and the VEGF 
receptor FLK1 in the infundibulum and an increased expression of FSHR in granulosa cells 
were observed. In conclusion, the exogenous FSH treatment increased the expression of 
FSHR in granulosa cells that was though not followed by an increase of oestradiol synthesis, 
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suggesting an impairment of granulosa cell function. It results an altered steroid profile 
affecting in turn both the expansion of cumulus cells during maturation, and the contraction-
relaxation of the infundibulum, confirming the hypothesis of a failure in ovum capture in 
superovulated buffaloes. 
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Conclusions 
 
In conclusion, the results of this thesis taken together highlight the limitations of MOET in 
buffalo, suggesting that at present the only way to improve the intensity of genetic selection, 
through the maternal lineage, in this species is the OPU-IVEP technology. 
Indeed, buffaloes do respond to the gonadotropin treatment with multiple ovulations but the 
ova capture is severely impaired, resulting in poor embryo recovery/corpora lutea ratio after 
uterine flushing, compared to their bovine counterparts. Nevertheless, the outputs of this 
thesis led to an improved knowledge and understanding of the limiting factors of the 
superovulation technique in this species. Beyond the high inter-individual variability, also 
described in other species, the major limiting factor in buffaloes is the low recovery rate 
likely caused by an impaired capture of the oocyte, both due to an altered extracellular matrix 
development, indicated by decreased cumulus expansion, and to an altered contraction-
relaxation of the infundibulum, suggested by the modified expressions of key genes. Both 
phenomena are known to be under the control of the ovarian steroids that are reduced during 
the peri-ovulatory period in the FF of superovulated animals. Furthermore, it is not possible 
to preliminarily select the donors to be enrolled in MOET programs in a practical way. In 
fact, a reliable method to measure plasmatic AMH levels still needs to be developed in this 
species, leaving as a possible option the assessment of the AFC or the less practical 
measurement of intrafollicular AMH. To complicate the scenario, the selection of animals 
with a higher number of follicles does not seem to be advisable because in these subjects the 
percentage of oocytes exhibiting a proper expansion of the cumulus cells was decreased. 
Moreover, the replacement of the last four injections of FSH with a single administration of 
eCG within a superovulation protocol in buffalo failed to improve the embryo recovery rate.  
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Therefore, more research in this area is required to improve especially the embryo recovery 
following MOET in buffalo for this technology to be feasible in the field. In particular, it is 
essential to modify the superovulatory treatment in this species in order to avoid the 
alterations of steroid profile in the follicular fluid that do not appear in other species and to 
improve the expansion of cumulus cells during maturation, as well as the oviduct 
vascularization and motility. Therefore, in future perspective it will be worth evaluating 
whether the use of recombinant FSH may improve the steroid synthesis, likely affected by the 
LH contamination of pituitary extracts, and hence, the cumulus expansion and the contraction 
of the infundibulum, increasing the embryo recovery. Another possible strategy to improve 
ova pick-up and hence embryo recovery rate may be to evaluate different schedule of PGF2α 
treatment around ovulation, with the attempt to increase the VEGF and contractility of the 
oviduct, possibly combined with treatments aimed to improve the cumulus expansion. 
Undoubtedly, new advances in molecular biology might highlight other factors influencing 
the recovery rate or the FF steroid profile, and the identification of genes that play important 
roles in oocyte cumulus expansion might lay the basis for strategies aimed to influence gene 
expression or their products to increase cumulus expansion and hence the recovery rate.  
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